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     l;1,agnetic gu±dance of magnetic albumin m±¢rosphere Eor s±te
spec±x'･-ic delivery was investigated ±n mice and rats. AL"ter intL'-a-
venous injection in micet rnagnet±c microsphe-r･ es with l and 3 ym
d±amQier size weve loca:/jzed and retained in the targGt-site
(!ung) by appt i･cattlon ctF -Lwo perinaneh'LL magnets to the lungs.
                                           ny  -+-]n]ectxon )nto the -y･ enal axniery ln -rats also indicated "that "Lhe 1->Jm                                                   .t ttt                      . . .micr.ospheres we-;e concen"L'.'a-l ed in Une k'i, dney by a magnetic r"x'eld.
Vv:hen rthe rnagne"ts were not .applted, inowever･, 4t-he mlc]osphexes r"Qllow-
±ng intravascula-r injection were concentrated mainly in the liver,
xeqa]diess otr "Lhe rouie oi" admLntsixat-i.on. Such preferen"Lial
localization by magneti,c .m"eans suggesied tha"L rnagnetic alburnin
                                                    '                                                 --mic=･ ospheres could become e:Tfeci i･ ve drug carriers with site specif±-
city t･eoLr -Lhe de]i･ v･ery of/ clnemot'neiraLpeuthlc agxen"Ls ±n cancer therapy.
     Keywo r･ ds magne "Li c a L/ b um±n micros p be re; magnet±c f] uid;     ,v--'C pt-e'--...v..･-.
drug ca-rrieif; site speci･ fici-ty; dx,-ug deli, ver･ yl magneHI ±c guidance;
t i s s u e d ± s 'L -ri b u tt i o n
                             (3)
     0ne of 'the goal/s 1.n. ca-ncer chemotherapy has been to find rneans
for･ direc-l ing drugs se!ecti･ve･"1-'-y to ti-i"mor sit.es. The most ii".ieresting
appreach -Io thi,s rvrob±em today ts ntL'o en'i'rap p-oien't drugs in some
dr･ ug ca:rr･ i･ers wntch arA" ncn-tox-{c and biodiGg:fadab]e. Varlous
investigca"Loys have a`ctem.tr.ted to develop useful drug car.x±ers, based
on evaluttiion in vi"c-v-o and in vtivo experi'ruent"s.2'3" Recen't exarupies                          -"---.-m--.-H.- -i, nclude ant-fi i umo-r aaen･ts into ljposoraes>>(g;Valbumi,n mlcrospheyesX){7/
and rai/c.rMosp.heres in oM/ emuis±on-V VJe recenc' ly reportedi that 5Y
zlluorouracU･ en.trap.rved ±n albumin micmros-pln-..res was pmresent ±`n high
ieveis jn the ]i/ve.v.･ ofr fi:ice ar[`L'e: inirc"tvenous ±ntection>>[ll<.l})/land
suggest-:･d susta±･ned velease and p, yo]onged･ action o-i entrapp, ed drug
occur red ±n Eh r.- li･ c in a s- c ±･ tel)x9ii)/ia nd so li d carc inomateY Mo re recentiy ,
we yk･fi='o. oy-Led tinat ady-i amycin eniL-rapped' in album±n mic]nospheres showed
p]ronouncea" an"Lii "Lumcr activi"/ v oin A}･{i･ 7974 l±ve] rnetas't･ asis in ]fats as a
mo d e] wi L' h a n e x. p e r･ i, me n t -r.- L/ t uro,o x . I Xi F. o w .c.i v e r , i n "c rc a v e n o u s ± n j e c t･ l o n o ie'
those .drug ca･.r･ rle-rs as men"L-i･oned above r･ esults ±n t.heir uptal<e -pre-
                                                    -domS.n/aneL']}g' bx-/' tl･z･e Ltet-icu･loendot'neL/ i･al systel)),)(ZeVr 12i especlan , t･he
Kup :r 'fer ce ll s' ±n i he tt, ver .'i 3 "/
     Recen,t]y, I･xi±.Jidex deet a]))<L<2;X/suga.iesLLed "that since magnetic micro-
spheres ±nt･ectt･ ed ±nto tl".e venLLra] caudaL/ a:fteMy could be locallzed to
some e:<tent 'to a rtx-ede-terr.n.lned tail segment' by an ex"ce.v.･ nalllrr appMed
ma tg ne v" i, c tr te] d, magnet .{. ca )/ L/ y guided albumin m tr cii-"esphere s' en ha( rapped ±n
c-xrugs wou]d b' e ttse:Tu] as a d"T-: ug, del±x.r･e:fxy s'y+stein w±tln･ si･ t･ e sp, eci.fici:cy.
I,<ar."-o et a2,-)tx<3!;/] g" /a]so repcriet"･ tlnF.:>- poss±bti11, ty of/ ma,g･nepttic cont:rol or=
                                                                       }an"ituritor drug and pre})a-ra"Li･o-n oi "che fer-romagnetic mitomyc±n C
(4)
l
mic:roc&psu]es wi･ Vn sustained r･ elease pyoperty, responding -.o necessky
otf se]ecti've cancer･ chemoti erapy>)KJ5V'Ci(i site specific drug de]±very
of, ant±tumoLv- agents could be achieved with magneti･c raeans, `chis
deUver'v svstein would eUminate adve:rse side eff'ects that a-r･ e often       HL-
the seq-uelae o[" generatedi systemic dxug dist-yibution. This paper des-
cribe ihe utj]±t'),r o:F the magnetic a)/bumin rnicr'osp, here (E/erMo-colloid-`/
entr･ ap, ped alL'uva±n microsphe-r･e) as a drug car･ rier wit] targeic specifici't'tzr
b¥ rueasuN"･-ing rnicrosphe.T-e ±eve:/s ±n the lung and kldney after intMa-
venous and in"Lra-r, ena:/-a-r'Le.,.'±a] admlnist-ra-'iion, r, espect±vely. A
sho=/ { corninunicatti,on otr r'his tdvonk has been published>>JV/
                              (5)
l･L･LPI,ny.iER:iAiT.S .ts,l/v'D ME]THODS
     l'klateria]s Bovine serum albumin (BSA), in-ac-i ten V powde-r,
(sei･kagaku i<6gyo co. !.tct-.) cttsp,dV25i-hupnahn ser･ um alburni-n Y( -'
HSA, J' apan Radioisoi op･e A' ssoc i- a bi on) we ve used. A par "L' o f/ watG -r -"'
based !nagnetic flui･d wh±ch 'vJa-s a suspension containing FE7E},OA fine
particl/es, th･at deis raagneiit=ns, was obta±ned f･ .v-･orn Taiho Industries
Co. Lid. and colloidal rnagnetite was p-v/ epaved by the method or"
shir･vLe,ouzak'a et al.l6 per/ manent rmagneic (super Di,sc i'{agnet, No.
30730, inner･ radi/us 5 mm, ouiceif ifadi,us 9.S mm, thick'ness 6 ffdip,,
Edmund Scient-S -""rlc> with" a magnet.S.c i/n"Lroduction o:F about 3000 Gauss
was used.
     Anivaals b･'1,ale r,･Lice o:･" ICR strairi 'w･etgntng abou"u' 30 g and
male rats oi W±s'ta-r s"L-:'ain wc"i･ghing 210-250 g were used. The
an i･ In a] s we sce I?La i･ n･ ;t･ ainea'･ ill a envixo n･ rp.L-en "c o f/ con tro lled t' elnp E-; if ature at
24 .1, IO and pLrovided i"whi -iuh Or-ienta:/ regular solid cMet and tap wat･ er
cfi:d -1.2bxtura.
     Preparatjon or" }'1･agneti/c AIbumin lx':/lcrosphere-}vlagnetic albumi.n
micrcsphergs weirsL). p. :rep-ar･ ed w･i･ th BSA,or-HSA, and magnetic flu±d by
g,mi'gl.:'/lgl!Li!ge,i.,I'hl:,e;kbgl,,ini,Ll±gs.gr,Il.ai.)'klll.....,T,x,g'o,mers,,g.m.g
added to 2 itil di･s'ti:/'led wa-tex. Tln-is was added to 200 rnl o:r ]o
g(v/v) Spc":n 85 in cot't'onseed o±l and `Lhe m±.x""r.uire was emuls±fi･ ied
with ult,A'a ivurraxN9/(Ika 1･x,ierk) at 8000 or 20000 )rpm for 30 rain atL
100. Heat hardening ott microspheres was accomplished by exposure
to temperatur･e or= l800 foy IO min. Since tlie xange of pa-r"L'icle
(6)
size oE microsg,)he)ces !)repa-y･'ed at 8000 rpm was l-7 }nm, the l-2
and 5-7 pm m±crospheres were separated rrifom the 2-4 pm m±crospheres
by centrifuga"L"inton oE/ the m±cinrosphe)re suspension. When the )･range of
pa] ticle s±/ ze of microsphere p-repared a"L 20000 rprR was O.4-L.5
,uLm, "Lh,e rnic]･fosphe]es were used w.`.･thoufu z"urthe-r separatibn.
                                            t[rhe rnean partic]e si/ L7e oE microspheves was de-i e:rmined by a pho'to-
rnicr･ og:ra-phic ruethod. T･he magnetic ra±･cvespheifes are shown in the
scanning electren microsphex-e pho"uoniicrograph in F±gure lg and the
presence orr magnetites on t.h.e surr"ace of, micr･.ospheres was observed
wj t h "L n. Lwr-s e n e r･ g -v d i･ s p e r s i･ v e - t y p e X - r a y ru i c r･ o a n a' M y s ± s (F i g u M e 1 -b ) L
[rhe tr-inal .rr.i.±cr/ osp, heLre conta±n abouHi 50 9. rnagnet-"g'es by dry we±ght.
                                                    '
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                   fi
     In Vixio `NIodel zlor Car･ :rie-r fi--arrptyeti'nq ]n thG xl lysLL (w)xperimen"Lsr
the mouse lung was selected as a mode] ri or in vlvo tp-ntsting oi' micifo-
sE.)he-res riox "Lwo r,easons: (i/) T/'he lung tuinor oc¢upies h±gb- x-atios
in rflanv inalEennlancies, and (i, 1') "Lhe rn±c.'L･ osnhe-r･ es aftLer intravenous
     .                                           '
±njGc-.' ion pass th-r.ough thnv li'･na. until seq,uestration in the liver.
E-acl": i,n"ouse was fi ><ed on i='s back wi'thout an,esthesi･a. One mq oit=                                                          "
iJhe ] o-: 3 Fm micr･ ospher/e is;･as injected into the taU vein in mlce
±n 0.2･ rn] otr a suspension. [[Xvo rnagne'ts yvreve dir･ ectly ap-plted "L"o
               'iHl".e sid'e otF ea･ch mouse, ilna't･ ls, ihe bzea/smLi and back otC m±ce,
"chrouglinout "L'he e>;pe-ri.n.'･,eni so as to concen･`L'x.p-tte t.he m-5 orrospheres into
the lung. The m±ce z"e:re }<U/].ed IO or 60 min axCte-r adm±nistration,
(7)
and>xl<i!5"l-iabe]ed micros:v"in･eres in various t-`ssues were determ±ned
b y an a u te - ga rnma sc i･ n ti l, L/ a ti'l o n s r. e c t 2･ro me te r (Typ e 5 1] O, Pak a rd) .
     T･he kidney was seLect･ ed as a model ln the second experiments.
I/t is d±t,"z-icuL/i tL"'o coUect the microspheres in o'L-' her tissues except
the ]ungs or heay-L afte-r in`u'xtavenous. injection, so the route oE
adndnistL'-aiion yv'as chang,ed 'L"o lntra-arier.S.al tinjectjon. Each rat
was anesz' hes±z･ed rrirt.h pen"Lobarr]±tal sodlum at a dose of 60 mg/]<g i.p.,
ana x･7as n･ :-<ea on i"Ls back. Aammrs`Lir-ation o:r the microspheres
"Jn"--･ ough the rena)/ artery was carried out･ by cannulat±ng a poly-
eth-lene tubi/ .ng and tfo-Tming a nesy' vessel bypassing the original
a=･tm..rv.t because a polyethy,Iene tub±ng ±s easy to be used ]Eor an
inDect±･on. One rc･ug oi the L/ Bm ru±cTospn' ere was injected into the
le:･i-t -renaL/ ar-Le-rT-f'. [EX･va ]/n･agnpvAivs were dirrec"LLlr' p, laced Jch.",--oughout ic-he
expe-vjin.ents at bot･ ln sides ozl t･ ln.e leff, -u"･ ki･.a.ney which was exposed by
a+ mid li n e ab d o m.l n a :/ i/ nc is ic n . D is #c -r- ib u ti o n oi m:i c ro sp h e :r e s IO an d
60 ruin a ft･ e] admin ±, st .r- at iL on was examine di bv t･ he r･ ne thod desc ri bed
I,)yMeviousl/ li. 7]h･e dts-L' ribu'ti/ on oz/nX{L(l9f. aiburain mt:crospheres to
vari･ous oygans is Ltepresen-ied as Ob' o:F d'ose peL' g t±ssue or thaLL
                                                'in "" he who :/ e r' i･ ssue.
(g)
RE-SULT.'J'
lylacneti･c ResDonslveness oi lvlaanetic .M.icrospheres
     The macrnetic Ar.¢-sponsiveness oi･ the mlcxosphexes susDended in
O.2･ P.(v/v) polysor･ batL"e 80 solut-ion is shoxjm by the sequentiaL/ t.{-ffte
                                    'sequence pliotog:rap.b.s in ii/gu]rG 2. :/t is obvious tn' at the mlc]fo-
spht.).r･ es wcrfsre secl,uen-l i･ al:/ 'y locaL/ izeQ- on and arcound thte dtsc-iuagnet.
                                           .
:/n "L.hat L"oi:/ow, ±t was tested i･n deiail w'nefi hey or noic the ruicro-
spher, es wer, gev p-retlGr･ enilal]}･f inreloca"Lund i,n ".a=, get; s±`ies by & magnet)c
fti eld ar.p, ]ied x･;･hen tine iRicxos-'.'hexes viitrh high±y magnetic respon-
s±veness wtn:re in-i .v,-avenously in.jected to animais.
               -Fl[;-. Z
[Vissue Di･ si Lfi-but･ i/ on er･"･- M±･crosphe3･res ±n Mti ce
     nt･ssue a'ist･ -rSbutibn oi･ radioactrivi"Lv aLL -1"'O mln: ai'ter intravenous
injectdi{on of/ ma･.gnetEc ]L',±,crosr.h･er･ es i,s shor";,n ln F, 5Lgure 3. A' rCtA.-:r
inject-ton ctF -Llr)e 1 pin ;a±crospheres i･n rn±ce ztrtthout magnet (con･'tro]-),
aboui: 3.9 9.- otr. ihe adml･ni･ster･ ed dose (li8- Ote'/g t-ikssue at 'L.he con-
cen-L' :･-ation) r,J;･as z"ound in- il,ie lung. g･v-liown "L-he pa:ttjc±e size oE, "L-he
mi･ r:reslp･ho..M.es was. en･]ar.:g･ed i･ r･ om ] to 3 Bm j.n di･ametex, uptake or" the
3 jguTtr.i, m±crosr.h,e-Tp- iLn iL"he ]unqus i/ n/cxees.sed; f.r-om 3.9 2 of. dose (l5.8 9.-/
gitssue) ica IO.7 tt (5L/.7 9.-/g). V{;/ln-en two magnets were applied to
tje lun･gs, k･.l･z･e micr･ osrln.eif･e 2eveL/s ±.n 't-' lnte lungs increased about -r"ouac-S/
fo].d tt/'or tl:e l ur" rnic]osp.her･ es and t't,rice t/"or the 3 Lim nd-cncosnhe:,"e
co'k'apaLrted wjtia- each conttr･ ol. Af,"Le-r, in)'ection o:F the 3 pm miarosphGres.
                              (9>
a peak l'ung lev'el (±04.0 "b/g tissue) was measured, but the amount o:r
the microsph･eres ln tlne ]ungs r"J.=.s on]y 21.6 qb oi' the dose.
                     Fi g,. .3
                       v
     Wj en the 3 uin iniLcrospher･ es were ±n-jeciecS. s'n rn±ce, t]'-ssue di-stn-
bu'tion o:F "r-adieacic-iv±ty Av.t rtoO min is as shown in Figur･e 4, where there ±s
a]so the dist-r±/buti/on N]Jhen L.:,vo magnets were applied `co the lungs only for
the in±tiai ]O nd/n. The up, ta]<e oti the micr/osr.heres in the lungs
lncr･eased f/ r･ora/a･ i7.0 9. oi t'ne dose (67.2 9./g t-issue) LLo 28.2 Cb' (lll.3
%/g) cn:nd t]nat ±in- ihe splec'"n and, ]i･ve-r a'ecifGased when two magne4cs
vg･er.nv app]led :ror･ 60 mi/n. I,at･hap, pli･cai i･on o:F tu7o ruagnets foif `che
iirs;c ]O mi/n, tni ere was an i･ ni ttia! d±st.i--ibution ol" xadfoac?i±v±ty to the
]un-tt,s (T. iLgure 3) tro]lowed by rapld clearance £ycm the ]ungs and
L/oca]izat-ion i･n d:e lisre:r (r-igu:re 4).
                      r- /t                      l-if7.･ `-k
rVissue Di,stribut･.i,on c･f･' l.1,i/cr･ ospheres trn Raics
    Fiaur･ e 5 core･uparces ihe ti･ ssue di･ stiflbi.-i"Lton of' the l-pip micro-
sp'ne-v･es ai iO m±-n :,-ollogving. i,ntravenous and ii･Artr･ a-renal-arterial
admi,nist.'-at･ i･on with oLr witir].out appl±caLL-"Lon or" "cwo rnagnets to the
]eit kjdne'･y'. A.ft･ver･ ±ntrav･enous ±n-;ect-ion, t'n･e m"±crospheifes did
not' concepitra"Le in tl/ne kjdneLf and, ]ocaL/ i･zed mfv'-'.i,nly in tlne liver
regard]ess oi ap, plica't'.{-on o:F -L･ wo magnets io the kidney. The micifosp, heye
                                                                      /
                            ao)
level in the ktidney after･ intxaar･ te.-rial adrninistration was higher
than that afeLer intr･ avenous injection s"ith anCl wjLLhout magnets.
Adm±nistrati･on into the -rat renal artery vii"L-h magnets, on the other
hand, concentrated tihe m±crespheres on the ki' diney at 10 rnin to 56.4
96 oLrt t･ hq dose (47.7 g/g tissue), and th.Di vaiue was about 2.5-fold
hi,-qhey than that in the cont-Tol.                                              -
                   f-l7 . s
      Figur･ e 6 cornpar･ es tn' e ic-S.ssue distribution of "Lhe l F.rn micro-
spln.er･ es at 60 mLn. :i o]low±ng ±ntr'na-renal-ar"L'er･ ±al adminis-l ratlon
waltn' app]ication otF -Lwo raagnets to the lef't kidney for the inii±al
]O or 60 m±n. I,4itcrosplne-re level ±n the lef"Lm k±dnev was found to
be 56.4 9.- oxr/ `Jne dose (47.7 elo'/g e' ±ssue) ar- IO rn±n af'L'eT admin±strat±on
whe.n al,pJptying the two magnetsV. In con`L'.-as=' r'othis value, the
r"in: aci±on otr 'L'ln.e dose -Temaining a-i tln-e. sarae o-v･ gan at' 60 mln was much
less vihen iln"t" ruagnet was removed l/e m±n after, adm±nis-i -ration.




     Recently, in severv･ al la-bolato) )'es, it has corne io be realized
that magentic niicrospheres with magnetic responsivenGss may be
u s e d a s t a -; g e t h s e l e c ti v e ln o ra ± n g d e v i c e s in c a n c e -r c h G m o t h e r a p y .1 4 , 1 5 r l 7>
Also, a con･side)･rab]e ainount o:F infomat]'-on was pre.q.ented ]rega)rding
                                              tthe [rtatva otr "Lhe ]nlc-v･ ospher-es and thei-TL contn.-nts af/ ter in･jection
, , ×3.4,2]                It js, howeve], e:-:pe.T- i･ men-Lal]v obscure whetherto razs.                                  " .L
rnagentic gui･dance otr tiae mici/rosl)b-eres to the target sites such as
the lung and k±･ aTneL,' is possi･ble. ]n addition, no inEorflat-ion has
been a:/ltassed･ -regarding thp-. errii ect oj app, ]i･cation "Ltime ot! :che magnets
to -l he ta]ae"t.skes and r･ em.Loval lrom t'ne s±`tes on the behav±oif of          JLuhe mtc:･ osphewhv/ es i, n･. bL/ oo(ft. F] om a p,]el±minary r･ epor)l>(V/and these
studies, i･t ts ev±den"t 'L'hat -ii tni .a. adrnintst-yabion route oi the
m±cxosr,vher, es is care:･r･-ully selec-l ed a-'･'id ap-oUcatfon bime of magnets
"co t'ne c' ary･ret sites is ey/Jencled mag,netic a.uidance orFr the microspher･ es
to ihe sites sucln a.s ihe lung a-nd kidney and LLhe retenc'-ion or" the
m.iricrosp, he]r.D.s in those sites ±s r.ossibL/e (Figures 5 and 6).
     A sma:/ L/ f, ttactt±cn oE' the in"t-' r･ axienouslv adindnistered dose d±stri--
                                         "                                                  'buted to bine ]ungs is due to a simp]e .`.` i]ter effect ofr `che pulmonary
cap.M]ar/y ]nn..ds, a]tthough vasv"ular･ conor'trict･ :,on may play, some role
in ihe pmi i･fap, pt･ng process. A lak-ge i',--raction ±/s distr--ibuted Tnainly in
the livex high in re'ticuloGndov' heltal ce]l activ±ty. [rhis phenomenon
o:/: f/ i･]ic･ r･at'ion in the ]ungs 'v.ias clearly observed w･hen the paL,--L･ ±cle
size ofi "tine microsphex･-es changed f,-r･ oru l Bra -'ln di±o,mLLeider･- "co 3 Fm.
(l2)
However･ , with the l or 3 >)in m±crosp, he-res injected in raice, there
was a la-rge d±stribu-L" ion "Lo th.e lungs by the applicat±on of the
magnets, cogipared to no appltcatibn o:," the magnets (Figure 3).
Ivloreover, d±stribution of the microspheres to tn' e kidneys fo11ow±ng
i :r)e ±ntta -r en al-a r･ LL avr i, al admin is t-r ation di ue to a si mp le fi ltration
od "i-he supexficial and jux-Laraedullar>' gloiaeyu)ar ayerlj/Ywas not
neg]±gibly but PLhe microsphe-v･ elevel in the kddney with the rrtagnets
was hi･gher the.n rlhat w±th.oui the magnets (F"S"gure 5)V/
     Wirh "the 3 pru microspheres inject･ ed ±n mice, retention in the
lunqs rrihen app]yina the maanets was qr･ eater than tn" a"L- w±tl out   LJ -. .. nvL J "                             va-pplicatti･on.]) Those nmicrosp,vhere ]evels retained by an externally
applted rr･Lagnasvtic trte]d thn the lunc.fs clear･ ly decreased when the magnets
r"ie-re r･ e:,novea"(':"･ tigu:fe -t-l/). [f'ne p&ttern oi dist-ribution ±n the ]<idney
when thnv re･.agnets were r･emoved was similar･ "Lo thai in the lung
(Figure.. 6). The dacrea-'.se in t-he lungs o-r ]±dney seen be'tween IO
     'and 60 m±n trollok･xintt adminisiratten o-r' the 'i""icrospheres may be due
to r",;ashoui 'yriihi,nihe lu･ngs ox j<i,d-n.ey so tclna-l the mic:tosphex･es
inittally ".･.r･ap.ped are a]L/oTt7qdi t,o r･ ecLrculate in "Lhe bloodstream.
Tlae resalts ob"La±n.ecl E･ r･om,t the exi.)eriments o:F rernoving 'the magnets
indicate thai･ tlde app, llcation time oi- the mag,ents to Vne "Larget
s±tes is impor･ tant for :te".･ e.'･'･ition of･ raicr･ osphences in those sites.
(] B)
     A guar･ ded selection of･ t･.he adm±ndstratiop route is also
i m p o -r -L a n "L -F o x tr･ a n s p o ri in g ra l c r o s p h e re s t o t a :r g e t s i t e s . K a n k e
et al/ >-Yreported tha"L-` no clea-'･'cu-Lt dif･ :rerence in distribu'edon
va"L4L-e]ns was observed between intravenous and ±ntraarterialL
a d ru ± ni s t' :･ a ti o n o f, m ic r o s p, h e r･ e s . A )/ s o sj 6 h o i m e t a i '). <ig>/ -r･ e p o r t e d
                                            .
ihat tt'he r･out.m" o-r- a(l･rnLn±st.T.a'L-' ±･on had no eEtreci on the gross d±stri-
bution patto."r･n by studyi,ng tlne distr±but-ion of the po±yacxyla!ndde
rnic]･rop, a-ctic1/es afte"r. intr･ avenous and ±ntL'"aperiioneal injection ±n
                                                               'rnice. Z･rhe r･ esu]-ls sln,own in this pap, er, how･eve]r, found a clearcut
d±zl Eerence i/.n, `clnav d±,st-Abut･;5-on. ttattern to be piresent between intra-
ve-ncus and intr･ aar･ teri,al adpain±st-rat-ion of･- raicr･ osphG]es j.n ra"cs.
:'n' us, the di･s"L-ribution or"･ the ml･c:tosp, he-v･ es in vivo ai'ter diEieyen"L
                            ':r oui es oxr adrn i･ n± st 'L- at -i- on i, s rsu)aUv co rup li cai ed, and fu ir 'L' hey
experwh5 rnen"Ls and sui fiicteni･ discuss±on wou]d be nmveded.
     7he rt:･n/L",ount o:F microspheres retai-ned at the "target s±"ce (lung
Sn m.ttce) was 28.2 9.- o:･" -Lhe dose a-i 60 ra±n･ atrter, int.r-avenous injecticn
o:F thA.. 3-prn mtcrospher･ es at a fi:eld strengifn o:F abour' 3000 Gauss.
             '              'I,rsai,lur･"eio achi･eve g;ro..atexr Lreicent-ion o:･" inicr.osplnerces is mos4c p]robably
due i'o weak magtnet･ ic s"L:feng"Lln.. Y'gln..･.an tle sL'reng"L-h of vaagne"L)'c reield
is increased, -t' hi･ s val, ue inig/h･t be imp, ro'ved cons±dex±ng tha"L V"idder
e-: a]X>l･･Yt]Y/used" higlfi Tmagneti･c fie:/dstreng"h (8000 Oe) to ]eta±n
37-65 !d rni/cirosrgl/te:.es into tlne ta±･] af･-ter.v- x'nfi･.i.sion th.T"ough the vent]fal
caudal/ artery. As mentioned abover vaany d]ug carrja..rs wltich are
capalDL/ .fi o:"･"- t-t`a)n,s:･J･o:･-t･ i･ :･-,a d-v･ uq rr･,tolecu] G3 f-Tom ir'i e si.te o+i- a"･Dl±cai ±, on
(l4)
direct]y to the slte orf actibn have been develoDed.2'3> In the near
                                                               '   'futur･e some carriers otF -Lhern inay be used in the cUnica] fie]d, but
the uti]i･ty o.r-r some drug car･rters is restric-l･ ed because of the lack
of/ sr.ec±fici･tv- or selectiviti,7. Controlled ]ocaUzation of drug
ca .r. ri ers, ho wever, has been dii: ic ult to ach i, eve. Recently,
Grego:/t±adiK3x>/documLentm..d z' hat attemp.ts have 6een made to ratfonaUze
l±p/wosom･ue developrueni by -Lailor-ing thelr sttructur･e to the particula:r
b±/ologica] :,a-ilieu ±/n wh±cln TL'ney are iniended to act. :/n the case
oi magne'L', ±c a]bum±/n rc･"i･cr/ osp, heres,±t is certain "L-' haiL- this drug caxr-i-er
can be u,sed as a targe-L' -se±eciive hora±ng device.
     Stud'i･es ar･e D. Lresen`L]y, under way i,n our )aboratory to e:<a]nine
VnA.- s±･ t/ a sp, eci:r-'tci, "vy o"v"-i the drug andi ±".s ant-`, "Lun･nor efrl ect against
expexirnentah] lung tumor c'ziie:rt int:.aver.ous injecti,on o-r" magnet±c
album±n mi/cr･ osp, he-re-en.-Lz/napped anti-Lumox- agents.
     Acknos･i/ eaement T/'lne au"Jnors are g-s･"at.a.ri ul to "Jne Tailno
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Fla. 4.  "
CAPT:/ ONS
Scann±ng Electron b'!icrograph ox" lvlagnetic M±crospheres
a n d S p e c t r o g -ym a m O b t a i n e d w i･ t h a n E n e rg y D i s p e r s ± v e - t y p e
X--x'ay .Nlicro&nalvsls    -"Sequential Time Sequence Photogr･ aphs of }J!agnetic Micro-
                                   .
spheifes xn Aqueous Suspens]on att.n.r a D;/ sc l･':/agnet is
applied
T, issue Distri bu `Li on o r" Rad io ac ti vi 'c'}iyl>{± O min after Zn tr ave nous
In]ection o:/ }･:,agnetic MLcrosphe-yesm Mrce (l arxd J >jtm
±n diamLe'L"' er)
   A; l pra in aveifagmv diarne"Ler･ , B; 3 prn in average diametex
 i[III ]; cont."Lroi (no raagp.et), ooeo"`; ireatrne.nt with two
ruagnekLs throughoi"i.t the e:t;per･ i/ m.en"Ls.
ResGlis a:,-e expifessed as tlne mean + s.E. of 3-s mice.
T･ tssue Distribut-ion of Radioac-l lvit'{f a"c 60 min afi;er
Irxt-ravenous ]nie:tion of -Lhe 3-vuin Magnetic Microsphere
in :/vlice
 Ur; control (no magnec'), "o"o:-;"L'reatment wirh two
inag,nets :/-o]･r 60 rft±n, mo ; tr-ea'Lrnent with ts･,7o ruagnets
tfor ihe ±ni L' i-a l/ ].0 in i- n.




T±ssue Distribution of Radioactivit'v at IO min after                                   "
In "L ravenous or Ini raari en' al Ad rninistration of tr 't". .' .- --
M)crospnereSln Rats
M; intra-renal-artery (no rnagnet),
 o:o:e:oO ; jni ]:a-xenal-ar"L'er> '(witn' magne"L)r
                                   .M ; in tra taU ve in (no magnet) ,
"l-II'/"';l'i"'i ; intx-ata±l vein (w-i--i h magnet)
Results a-re exp-ressed as the mean ±, S.E. o:,rt 3-5 rats.
g]±ssue :itt:=ibution o-rr Radioact-ivYLv at 60 rnin after                                   x
Intra--renal-ax"-l e-rinl Admiri±s-trattion o:F l-pm b"lagnet±c
tvticr･ ospheres ±n ].ats                                            ''Lr; contyol (no rrLagnet), O"O""ee, ; treaicment wi"ch
t'g･;o inagne`L-s G':-+o-r 60 mti-n, M 7treai-ment wLth two
rnaanets :l o if 'L' he ±n it -i al IO min.  J
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Brug-carrier Property of Albumin Microspheres in Chemotherapy. II.i)
        Preparation and Tissue Pistribution iR Mice of Micro-
                  sphere-entrapped 5-Fluorouracil2>
KENJI SuGIBAyAsm, YAsuNORI MORIMOTO, TANEKAzu NADAI, YosHIo KATo,3a)
              AKimKo HAsEGAwA, and TAKAicm ARiTA3b)
Facztlty of Pharmaoeutical Scienoes, Josai Univeptsity,3a) and Facztlly of
         Pharmaoe?dical Sci'enees, Hokkaido University3b)
(Received August 2･3, 1978)
   Bovine serum albumin rnicerospheres containing 5-fiuorouracil-6-3N "rere prepared
by heating at 1800 (or 1500, 1000) of 25% albumin solution in cottonseed oil emulsion. The
shape of this microsphere was invariably spherical, and the average diameter was O.66 @･
After intravenous injection in mice, 5-fluorouracil-6-3H entrapped in albumin micro-
spheres localized mainly in the liver, and the disappearance rate of radioactivity in micro-
spheres from the tissue was very slow in comparison with that of free drugs. The micro-
sphere might be delivered into reticuloendothelial system in the liver because ofits phagocy-
tic activity, as weli as the distribution following injection of albumin macroaggregates.
Such preferential localization and sustained release of entrapped drugs suggested that
albumin microspheres are useful as drug-carrier in chemotherapy.
   Keywords albumin microsphere; antitumor agent; drug-carrier; reticuloendo-
thelialsystem; phagocytosis; drugdistribution
    After the drug is absorbed or injected into the blood stream, it may be distributed
generally throughout the body in the medium of the body fiuids. It is well known that the
rate, extent, and pattern of the distribution are determined by the physicochemical charac-
teristics of the drug. As antitumor agents frequently exert undesirable toxic effects, locali-
zation of the drugs to tumor sites would reduce･the side effects. Then it is desirable that
the antitumor drug selectively reaches its target tissues in drug therapy.
    Past approaches to targeting of chemotherapeutic agents have been largely related to
several drug carriers. Most tumor cells have been shown to phagocytize some spheres.4,5)
If a drug carrier containing an antitumor agent is phagocytized into tumor cell, the carrier
may be digested with lysosomal enzymes in the cell and free active drug may be then released
to the environments.
    Trouet, et al.6) reported reduced toxicity and increased effectiveness in the treatment of
leukemia when DNA complexes of antitumor agent daunomycin were pinocytized from
selutien. Fiirthermore, they found that the free active drug could be released froBL DNA
complex after digestion of the complex with lysosomal enzymes. The use of liposomes
(phospholipid vesicles) as drug carriers has been noted recently. Gregoriadis and his coworkers7)
1) Preceding paper, Part I: K. Sugibayashi, Y. Morimoto, T. Nadai, and Y. Kato, Ckem. Pharm. Bull.
   (Tokyo), 25, 3433 (1977).
2) Part of this work was presented at 98th Annual Meeting of Pharmaceutical Society of Japan, Okayama,
   April, 1978.
3) Location: a) 1-Z Keyahiaai, Sakaao, Saitama, 350-02, faPan; b) Kita 12-,e'o, Nishi 6-ohome, Kita-k¢e,
   SaPPoro, 060, fapan.
4) RE Gilfillian, Cancer Res., 28, 137 (1968).
5) I. IPalyi, Aroh. Geswzclsi!forsch, 33, 345 (1969).
6) a) A. Trouet, D.D. Campeneere, aRd C. de Duve, Nature (London),239, 110 (1972); b) A. Trouet, D.D.
  Campeneere, M.D. Smedt-Malengreaux, and G. Atassi, EuroP. J. Cancer, le, 405 (1974).
7) a) G. Gregoriadis and B.E. Ryman, Eu7oP. J. Bioohenz., 24, 485 (1972); b) G･ Gregoriadis, FEBS
  Letters, 36, 292 (1973)･ ･･
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reported that liposome-entrapped drugs iRtravenously injected into rats were concentrated in
the !iver and the spleen by phagocytosis in the reticuloendothelial systems. Gregoriadis and
Neerunjun8) investigated the possibility of hoi ning iiposomes to target cells by using liposomes
associated with molecular probes which exhibit a specific affinity for the surface of a variety
of normal and malignant cells. Radiologists utilized the phagocytic activity of the liver
and.the spieen to study and diagnose the function of reticuloendothelial system by radiolabeled
albumin microspheres.9> Kramer, et al.iO} reported that human serum albumin microspheres
containing 6-mercaptopurine were phagocytized by HeLa and glioblastoma in vil7'o, and they
suggested the possibility that the albumin microspheres could be utilized as drug carrier.
   We have recently reported that 5-fiuorouracil (5-FU) entrapped in bovine serum albumin
microspheres localized in the liver after intravenous injection in mice.i) In this paper we
wish to report physicochemical properties of albumin microsphere and its usefulness as a
drug carrier.
Experimental
   Materials 5-Fluorouracil-6-3]EI (3H-5-FU) was purchased from Japan Radioisotope Association
(Tokyo, Japan). Unlabeled 5-FU was supplied from Kyowa Hakko Co., Ltd. Bovine serum albumin
was obtained from Seikagal<u Kogyo Co., Ltd. and cottonseed oii vLras selected as a vegetable oil.
                                        Preparation of Albumin Microspheres Bovine serum
25% BSA 5-FU solution 10% Span 85
    (or suspension) cottonseed oil
               x/
            emulsifying (w/o)
                i
                heating
                s
         microsphere/oil suspension
                  t
            separation from oil
                t
                drying
Chart 1. Schematic Diagram of Prepa-
 ration oi Albumin Microsphere Con-
 taining 5-FIuorourac l
of adhering oil, the preparate was washed in
precipitates were stored in a desiccator. And just before experiments
with O.2% polysoTbate 80 and sonicated at 100 W for 10 min so as to
to he surface of the micro pheres. After centr!fugation,
sorbate 80 in O.9% NaCl solution and suspended well with an ultrasonicator.
   Preparation of Albumin Macroaggregates Bovine serum albumin macroaggregates containing the
3H-5-FU were prepared by a sli.crht modification of the method of Thomas, et al.ii) Tbe macroaggregates
were prepared on demand. Twenty five mg of bovine serum albumin were dissolved in 1 ml of radiolabeled
5-FU solution. The pH of the solution was adjusted to 5.7±O.2 with O.1N HCI. And the solution was
heated at 9eO for 10 min uRder continuous stirring. In order to wash the macroaggregates and "Lo remove
 albumin microspheres containing antitumor agent 3H-5-
FU were prepared as follows by modification of the method
 o'£ Sche'ffel, et al.9b) (Chart 1). Two hundreds and fifty mg
of bovine serum albumin were dissolved in 1 ml of radio-
labeled 5-FU soiutjon. The resuiting solution was mixed
with 100 ml oMe% span 85 in cottonseed oil, and homoge-
nated with a motor driven glass stirrer (Tokyo Rikakiki,
Model MS-75) at about 2500 rpm for 10min, and was
furthermore emulsified with an ultrasonic homogenizer
(Nihonseiki Seisakusho, Model G50022-4) at 100 "r fof 30
min.
    Another 100 mi of cottonseed oil were heated to 1000,
1500, or 1800 in a 500ml three necked round-bo'ttomed
fiask under continuous stirring by a glass stirrer at 2500
rpm. T  homogenated albumin-oil was gradually added
to the heated ojl, the temperature was adjusted to 1000,
1500, or 18eO, and heating and stirring was maintained for
10 min. After the suspension was cooled to room temper-
ature, ach suspension was mixed with 200 ml of diethyl
e r. The mix ure was separated by centrifugation and
the oil-ether phase was discarded. For complete removal
ther and in ethyl alcohol. After vyTashing the spheres, the
                , the dxied microsphere was dispersed
              remove the free drug l osely adhered
          the pr cipitate was dispersed with O.20/. poly-
 8) G. Gregoriadis and E.D. Neerunjun, Biochem. BioPhys. Res. Commun., 65, 537 (1975).
 9) a) I. Zolle, B.A. Rhodes, and II.N. VLTagner, Jr., Int. J. APPI. Radiat. IsotoP,, 21, 155 (1970); b) U.
   Scheffel, B.A. Rhodes, T K. Natarajan, and H.N. Wagner, Jr., f. Nescl. Med., 13, 498 (1972).
10) ) P.A. Kramer, J. Pha7m. Sci., 63, 1646 <1974); b) P.A. Kramer and T. Bumstein, Lofiz Sci., 19, 515
   (1976).
11) J. Thomas and S.N. Vgriener, f･nt. J. APPg. 1?adiat. JsotoP., 25, 463 (1974).
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iil:, {,r. il.,!'l.･ /fSla,t,1,?MP,ti J.{asLa.l :l,l;e:,,:gge,d.;,O.`,hSE,MaC.'e,a,'ICFg8i7,E.e.S.":..d,,t.b,e,st,iSP,e.nBIO,n.,,w.,:g,Z?ii;lz`i:d,,at:
sLispe ' ,n "'a.s obtained by disperslng th'e mixtvre w]th an ultrasonEc aloaner CBranson. "･IDdel 220) arid used
rc.,r ammaT expcrimeilts.   Dru.e. Distribtition in )Ilce JCL-ICR inice sveighing abOut 30 gwere tisedin a]lexpcriment.T. ',H-5-FV
"-zE iniec'rc･Ll into miee thrvu' h tail vcin ,in ().5 inl soiutiOn CO･9g'o' NaCl sOlution), O.fi ml suspension pf alburnin
i,ii/1111,,/:,i,li3i)il'illrk;L//f,I,,i:i'l,2,g:'i?,/r,/;,loi./?./;i･:i/li/ii'/k,(,/e,SilTl,/ki/i/gei,/[a,'llll･liita;.i,':e.//il{?C,//i,te.{'//ihz,r.s"ecli,'[d,'/j,ilp/liiSi'¥o,//a,i.!,lfl,?.:/1'il'g'
wcre ni 'ttreLl for rudiQactivity wit]i a liquid scintillatien counter (AToka, Model LSC-651).
   Experimental Tumor Systern in Mice Ehrlich eaJeinoma aseites vv'oTc tranGplanted intTaperitoneaUy
tt] ICR ini tboth nmles aiid females. avg ivt: 30 g} at evet]' ten days. This treatment was the invculation
i tli El'Lrlich iL".ciLes :) u. If)T cellslO.Lt5･ml. Ehrlich solid carCinoma "'as prepared "'it]i the methwd which
I!hrliclz ascitvs C? '< 10T eell/siO,L)[) nil) "'cre injeeted Subcutaneoll$Iy lito the scnpular re,:ion of mal(i iiiisc.
Thc inicu wL,ie tisef/1 fer the experiinont tenth diay 'after the lnjeetioii o±' Ehr]ich ascites.
Results and Discussion
(1) Physicochemical Property of Drug-entrapped Microsphere
    ThLT sliupe of a,Ibumin microsplie:es was invariably spherical probably due to tl'ie prepa-
ration methtid wliich the inner alhumin phase' of wto emulsion was immediately soliclifiecl at
hig'h temperuture. I:igure l sl]ows the scanning eleetron microphotDtsvraph of niicrnsl]1ieres.
Tlie photogr'Lzph was taken after tl}e metal coatingwas carried out on mi¢rosphere.t with an
ion-cf}ater. (Jliko Seiki, Model IB-:',;)
    1'he uo clistribution of albumin microsplieres was cleterminecl with a IV{odel Zb Coulter
CBunter. IJIguve2sliows thesize distribution of albumin inicrosplie･ros prepared at ISU''. Tlie
mest frequently occurring cliameter varied be'tween O.i and 1.0 ti. and average diameter 'was
U,6[i [i. Tlic., g. ize distyibution of niicrosplieres was mainly depending oii the particle sizc of
emulsifm i]'i the first step c}f tl]e preparati{)n ef microspheres, and that particle size wtts
lnfiuenr'ecl bv the concentration et ernulsiSer an{l meehalli{)al agittttion.r2)
    Tlie niil'rosphere is physieally attd cheniically stable, Aiter :･J-1"U powflc-.'r was 1)eutc･(1 fLt
1'SO" fL)r ]" ]nin, we deterniinecl tlie weiglit changes of the powder, UV spectruni of `-J-I"U li]
an a['et:Lte 1iuffer (pH 4.7'), and abserbance of the 5-FU solnticm at 26ti nm. The ex'idanc'e
                              '`-i-2i"i
1,lg.. 1. S'cn ag' Electron )Iicro'photo.ffraph of











     Diameter of tuicrospheres Cp)
F{g. 2. P[Ltticle Size und Distril)n-
 kton o[ Albu"xLa }'!icrosph¢re pi'e- paretl at ISC}"
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  e   Free 5-FU albumln alburnin microspheres
           a.rrgregates (180") (150P) (100e)
Fi'g. 3. Time Course of Tissue Distribution of T{a-
 dioact vity after Intraveneu", rnjection of Free 5-
Fluorouracil, Alburnin Mgecroaggregntes} or Three
 Types ol AIbumin Micresp]]eres
     msSl : lung, N: sp]een, M: liver` EiiZ : kidueY
   Eacli eultmm reprqsents the muan value af at lcast thrF,e
 nieAs"[cmerLtg. VErtlenl be[s iadteate. IS,E.
are phagoc}rtized by retieuloendothelial systeni of tl]e liver.
soliclified at 1800, about 70el, of dose were localize
liiglier than the raclioaetivity in the lixrer followin.ff jnjection
albumin including drug. The microspheres prepared
reticuloeudothelial system because of its high pliagQcytic activity,
tion iollowing injeetion efi the macroaggregates.
microspheres were prepared effects bio-distribution
tion. Tlie microspheres prepared at ltbOC er 1000
but also in the lung, as shown in Fig. 3. Zolle,
rnicrosphere was suspended in a $elution, swelling occurred, aiid tlie
on the temperature at w]iicti tbe microspheres were prepared.
refiected in the accuniulation ill the lung, and the
increasing in size of the microspheres, occasionally, oecurs to
and pulmonary embolism.i`iii4] Such localization of entrapped
that albumi,n microspheres arc potential drug aarriers in cliemotherapy.
    Furthermore, we studicd the drubtr carrier property of microsphere,
of the disappeatance of radioactivit.v in the ]iver and lung from ID miii
 oE degradation of t')-FU by heating was
 not ieund in the results. ivX'hen the
 all)umin microspheres were preparecl by
 the metliod deg. criberf pTeviously, abcmt
 .L`1 of ,U)-FU present in c)Figinal emulsioll
 wRs associated with the mlcrospheres.
 In contrast, entrzpmc/nt of ,1-1iU in
 albuminmacr()aggreg'ates vvuF G"'..
 (2) Tissue DistributiDn in Mice
     1;igure 3 shnws the distributian ol
 [adioactivity to variout orbrrans. at IC'),
 "t), aiid Lt,10min after intravenotts in-
 iectionoffree3H-t)-FU,threet}.T)esofal-
 bumin micres.pheres or albumin maero,-
 aggregates. In tl]e figu:e, the distri-
 buticm is repre,sentcd as Cj,<, c}f dt' ' per
 "Thole tissne. Soon aftef inject tR of
 non-entrappecl 3H-5-FU, most radioac-
 t vitv was remGvecl from tlje eircula-
 tivn and some of it transientlv was tn
 theliverandklclney. But radioactivity
 in the liver decrcased irum :LL'.79/e (IO
min) tn 1 Oa･' (210 min). In cvntra:st,
 albtun n macroaggregates entrapped
 d ug was accumuiutecl mainly in the
 iiv･er (abeut 10"X, at 10 inin), and 10%
ef dese were nieasured in the 1isrer at
 a,hr. The macroaggregates･ 1iave been
 ilized as a scanning agent, ancl they
       In case ol albumin mic Qspheres
 d in tlte liver, This value was much
      oi free dnig or macroag J'ebcate
  at ]80" might bc delii red into tlie
             as we]1 as, tlie distribu-
The te pe ature at which t!ie albumib
of radioaetivity a.fter i travenous injec-
w re aceumu ated not onlv in the liver
 et aJ.9a) pointed ut that whe･n the
            clegree of swelling depencl d
        Thi  swelling "f micros'phere
liver a･s we l. And tlie c]iange, tliat is
      ebliteratleii of pulmonar]/ vessels
        drugs in the liv r sutsogested
13) H.)T: Wagner, Jr., D.C. Sabiston, Jr,, J,G, McAfee, D. Tow, anfl I{,S.
   377 (1964).
14) J. 5zymezdera, O. Miocluszewska, I. Licinska, A. CzaTnoniska, and B.
   (1977).
 TIie time c urses
to 3 day follewing
stern, Nffw En.gi. f. Sfeal., 271,
Luska, 1. Nttcl･. Med., !S, 478
t
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administration of three types of microspheres in mice are shown in Fig. 4 and 5. The disap-
pearance of ra{tioactivity in the liver was very slow. And the elimination of radioactivity
from the lung was faster than that from the liver. Amount of drug accumulated and the
elimination rate depended on the temperature at which the microspheres were prepared.
The elimination of radioactivity after injection of microsphere prepared at 1800 was slower
than that after injection of spheres fixed art low temperature. Other work from our labolatory
has shown that in vitro drug release from the microsphere entrapped 5-FU continued over a
week, although the release rate was slow.i5) Therefore, these microspheres in the body may
be disintegrated gradually and 5-FU entrapped in microspheres may be released. These
results suggest that the albumin microspheres are instructive drug carriers with sustained
drug release property, and it is expected that the microspheres are useful for maintenance
of clinical effectiveness or therapeutic concentration in the tissue. Furthermore the release











  otsex -24-48-72                  hr
Fig. 4. Time Course of Drug Amount in the
 Liver after Injection of Microsphere pre-
 pared at 1800 (A), 1500 (O) 1000 (M)
  Each point represents the mean vaiue of at least three

















   x-X24gttirr----",fe "pa,H-Xm-al`-wh,O,
                  hr
Fig. 5. Time Course o£ Drug Amount in the
 Lung after Injection of Microsphere pre-
 pared at 1800 (A), 1500 (O) or 1000 (O)
  Each point repyesents the mean value of at least tiifee
 measureineRts. Verticalbars inclicate ±S.E.
(3) Effk)ct of Pretreatment with Nen-eRtrapped Microspheres on the Tissue Oistributioll ef
Drug･-entrapped wacrosphere
    We studied the effect of pretreatmeBt with non-entrapped albumin i[iicrosphere on the
tissue distribution of drug-entrapped microsphere. Non-entrapped microspheres and drug-
entrapped spheres were prepared at 1800. After the mice were pretreated with administra"
tion of non-entrapped microspheres (5 mglO.5 ml), drug-entrapped microspheres (5 mglO.5 ml)
were injected at 5 min. Figure 6 shows the tissue distribution at b'O min following injection
of drug-entrapped microspheres. Amount of drug accumniated in the lung of microsphere-
pretreated mice increased and the uptake in the liver and spleen decreased, compared with
a control (without pretreatment). Because the phatgocytosis of the microspheres in the
liver and spleen might be saturated after first injectien of the microspheres (non-entrapped
microspheres), the amount of drug accumulated decreased following second injection of the
microspheres (5-FU entrapped spheres). In contrast, since the phagocytosis in the liver and
the spleen was saturated, the uptake in the lung might gradually proceed. As the phagocytic
activity in the lung may be low, it is doubtful that uptake in the lung occurs only by phago-
cytosis. In order to clanfy the uptake mechanism, we are now iltvestigating the histological
study in some tissues after injection of the microspheres in mice.



















  o       lung spleen liver kidney
Fig. 6. Effect of Pretreatment with Non-
 entrapped Microsphere on the Tissue
 Distribution of Drug-entrapped Micro-
 sphere
 [ :coRtrol
 ua: pretreated with non-entrapped microsphere
  Each columm represents the mean value o£ at least













            spleen kidney
 Fig. 7. Tissue Distribution of 3]E[-5-Fluo-
  rouracil entrapped in Microspheres at 30
 min after rnjection in Tumor Bearing
  Mic
   Each column represents the mean vakies of four





0 lung liver tumor
(4) Application to Tumor Bearing Mice
    In order to study the effect of the albumin microspheres on Ehrlich solid carcinoma in
mice, we measured the radioactivity in the tumor tissues aftey injection of 3H-5-FU entrapped
in albumin rnicrosphere prepared at 1800 (5 mglO.5 ml) into tumor bearing mice. Figure 7 shows
the tissue distribution of tumor bearing mice. The microspheres were not preferentially
localized in the tumor cells, and most of the radioactivity was accumulated in the liver.
    Gregoriadis, et al.re6) found that a degree of preferential uptake of liposome was observed
in malignant deposits in most organ. Such preferential localization of liposome could be
explained by an increased accessibility of the diseased tissue to liPosomes due to extensive
local vascularization o  to an increased endocytic activity of tumor cells, or both. But
Newtoni7) suggested that access of dye penetration to tumor was poor. The uptake mecha-
nism of drug or drug-entrapped carri r to tumor cells should not be a simple process, but a
comp!ex process which varied with the different tumor cells. We will study whether the
albumin microsph res are valid o several experirnental tumor systems, especially hepatoma
cells. But f targ t tissue is in the liver, the albumin microsphere is useful drug carrier with
i s selectivity for the liver and pr ionged action. We will make a study of possibility to direct
drug-entrapped albumin pheres to target tissues other than the liver through specific
manipulations of the microsphere surface.
16)
17)
G. Gregoriadis, C.P. Swain, E.J. Wills, and A.S. Tavil!, Lancet
]K.A. Newton, Brit. 1. Radiol., 38, 224 (1965).
, 1, 1313 (1974).
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Drug-carrier Property of AlbumiR Microspheres in Chemotherapy. I.
           Tissue Distribution of Microsphere-entrapped
                    5-Fluorouracil in Micei)
   After intravenous injection in mice, 5-fluorouracil-6-3H entrapped in albumin
microspheres localized mainly in the lixrer, and the disappearance rate of radioactivity
in microspheres from the tissue was very slow in comparison with that of free drug. Such
preferential localization and sustained release of entrapped drugs suggested that albumin
microspheres are useful as drug-carrier in chemotherapy.
   Keywords albumin microsphere; antitumor agent; drug-carrier; reticuloendo-
thelial system3 drug distribution
    It is desirable that the drug selectively reaches its target tissues in drug therapy. After
the drug is .absorbed or injected into the blood stream, it may be distributed into the inter-
stitial, cellular, and transcellular fiuids. The rate, extent, and pattern of the distribution
are determined by the physicochemical characteristics of the drug. And the undesired
effects of the drug sometimes arise because of the accumulation in other tissues except for
target tissues. In particular, since most antitumor agents lack tumor specificity thereby
resulting in dose-limiting systemic toxicity, these drugs should be delivered to target tissues
correctly.
    Past approaches to find method of directing drug-carrier to paticular tissues have been
largely related to drug-containing liposome (phospholipid vesicles). Gregoriadis and his
coworkers2} reported that liposome-entrapped drugs intravenously injected into rats were
concentrated at the liver and the spleen by the phagocytosis of the reticuloendothelial system.
Tanaka, et al.3) also reported similar results that liposome-entrapped i4C-inulin after intra-
venous injection were recovered mqinly in the liver and the spleen. Trouet, et al.4) reported
reduced toxicity and increased effectiveness in the treatment of leukemia when DNA complexes
of the antitumor agent daunomycin are pinocytized from solution. Radiologists utilized
the phagocytic activity of the liver and the spleen to study and diagnose the function of the
reticuloendothelial system by using radiolabeled albumin aggregates, aibumin microspheres
and sulfur colloids.5) Kramer6} suggested the possibility that albumin microspheres could
be utilized as the prominent drug-carrier with tissue specificity. Drug-carrier property
of albumin microspheres in chemotherapy also appeared to be of interest to us. In this
paper we wish to report the tissue distribution of 5-fiuorouracil (5-FU) entrapped in albumin
microspheres after intravenous injection in mice. Albumin microspheres are physically
and chemically stable, are seJectively removed from blood stream by the reticuloendQthelial
system, and are nonantigenic and metabolizable within the body. Wagner, et al.7} reported
1) Part of this work was presented at 97th Annual Meeting of Pharmaceutical Society of･Japan, Tol<yo,
  April, 1977.
2) a) G. Gregoriadis and B.E. Ryman, Eu7'oP. J. Bioohem., 24, 485 (1972); b) G. Gregoriadis, FEBS
  Letters, 36, 292 (1973).
3) T. Tanaka, K. Kobayashi, K. Okumura, S. Muranishi, and H. Sezaki, Chem. Pharm･. Bull. (Tokyo), 23,
  3069 (1975).
4) A. Trouet, D.]). Campeneere, and C. De Duve, Natztre (London), 239, 110 (1972).
5) a) I. Zolle, B.A. Rhodes, and H.N. Wagner, Jr., lnt. J. APPI. Radiat. fsotoP., 21, 155 (1970)j b) U.
  Scheffel, B.A. Rhodes, T.K. Natarajan, and H.N. Wagner, Jr., J. Nu.nl. Med., 13, 498 (1972).
6) P.A. Kramer, J. Pha7rm. Soi., 63, 1646 (1974).
7) H.N. IiNTagner, Jr., D,C. Sabiston, Jr., J.G. McAffee, D. Tow, and S. Stern, New Ei･zgl. f. Mea., 271, 377
  (1964).





































                 entrapped 5-fiuorouracil-6
                               accumulated
                               similar to
                             today are phagocytized by the
                          microspheres
                         phagocytic activity
              lbumm microspheres led to a dramatic chan
    After the microspheres were administered into the mice, disappearance of th
in the liver was very slow. Other vvrork
drug release from microspheres entrapped
the release rate was slow. From these results,
tegrated gradually and 5-fluorouracil entrapped
expected that the albumin microspheres are usef
or therapeutic concentration in the tissue.
entrapped drugs in the liver suggested that albumin microspheres are potential as drug carrier
in chemotherapy. Work is now in progress
tumor bearing mice.
       Liver Lung Kidney Spleen
  Fig. 1. Time Course of Uptake and
   Persistence of 5-Fluorouracil-6-3H
   in Tissues
 M: microsphere-entrapped 5-fiuorouracil.
 [ ]: non-entrapped 5-fluorouracil.
  Each column represents the mean value
 of 3-5 experiments.
  Vertical bars indicate S.E.M.
min). Incontrast,
a considerable amount of the drug
later as shown in Fig. 1. This is
as scanning agent in clinical use
of the liver. The a}bumin
system because of !'ts high
of the drug ina ` '
that they administered aggregated albumin in more
than 1200 studies in over 300 subjects and were
unable to detect any evidence of antigenicity.
Therefore the results satisfv the criteria which a
substance should possess if it" is to be satisfactorily
employed as drug-carriers.
    Bovine serum albumin microspheres containing
the antitumor agent 5-fiuorouracil were prepared
by a modification of the method of Scheffel, et al.5b)
Size distribution of microspheres was determined
with a coulter counter and the main part was in
the range O.Fl.O microns.
    In animal experiment, 5-fiuorouracil-6-3H vLias
injected into the mouse through the tail vein (ICR,
22-32 g), as O.5 ml of a solution (O.2% polysorbate
80 in O.9% NaCl solution) er a suspension of
microspheres. And mice were killed at certain time
intervals. Radioactivity in the lung, liver, spleen,
and the kidney was determined by using a sample
oxidizer and a liquid scintillation counter.
    Soon after injection of non-entrapped 5-fiuoro-
uracil-6-3H,-most radioactivity was removed from
the circulation and some of it transientry vg7as in
the liver and the kidney. But radioactivity in the
liver decreased irom 34.30% (10 min) to 3.14% (120
 ' -3H was mainly accumulated in the iiver, and
was still retain  by the tissue 120 min
a phenomenon tha  albumin macroaggregates
              reticuloendothelial system
  also are delivered into the reticuloendothelial
'' . These results suggested that entrapment
             ge in its etain ng in the liver.
                            e radioactivity
 from our own laboratory has shown that in witro
  5-fiuorouracil continued over a week, although
    the icrosph res in the body may be disin-
     in microspheres may be released. And it is
     ul for mainten nce of the clinical effectiveness
   Such good localization and prolonged action of
    on the effect of albumin microspheres on the
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SpeckgepbotgmetricARagysis forFluero as yacNisu BioSogical Fluids
Y. MORlMOTO, M, AKlMOTO,K $UGIBAYASHl  T, NADAl and Y, KATO          ,-
Fllivreuracil (5-I'{'luorouracil; ;")'-FU) is a. nionoanion at
pH == IO and forms an ion-pair comple;,t,with a (lu(･tter-
nary alkylanimonium ion. De Leevilieer and co-""orkers
[2]' reported that the ion-pair coinplexes inight be quan-
titatively extracted froni aqucous solutions into orsvan]c
solvents, anci thcy spectrophotometrically detern}ined
the concentral'ion of 5-IrlLT,. IBut as their niet,hod used
colun]n chroniatograph-v, it ivas cuinbersonie an(l tiine-
col)sul))111g.
I'Iere we present a niorc rapid cl)emical assay of 5-[[?U by
modifying theprinciple of their inethocl. The applicability
of this mcthod was shown bydeterminingtheplasmaand
tissue levels of 5-FU in mice.
Spektrefotometrische Bestinmrung von Fluorouracil alls
bio!ogischen Fltissigkeiten
Fluorouracii (5-l'iluoruoracil; 5-FU) ist bei pllrl == 10 ein
MonoanioB und bildet Ionenpaar-Komplexe mit quar-
temisierten AIkyla,mmoniumionen. De Leenheer und
Mitarb. [2] berichteten, daB Ionenpaar-Kon}plexe quan-
titativ aus "TaBriger L6sun.cr in ein organisches L6sutngs-
mittel extrahiert werden k6nnen. 5-FU lieB sich so
spelgtrofotometrisch bestinimen. I])och ist die Methode
durch Verwen(lung der SC zeitaufwendig.
Die hier bescln'iebene Methode zeichnet sich durch Ein-
fachheit und Genauigkeit aus. Das fotometrische Ver-
fahren kann zur Bestimmung des Plasma- und Organ-
spiegelverlaufes benutzt werden. Es wird unter deni
Aspekt des Einsatzes ftir einen Therapieservice geprtift.
1. Introduction
Monitoring plasma and tissue collcentration is required not
only for antibiotics but a,lso for antitumor agents so as to ratio-
nalize a method of administration, to strengihen the therapeu-
tic effects of the drug, and to dimj.nsh the side effects. In addi-
tion, so as to develop a new drug-delivervisystem of antituinor
as,cnts, the measurcment of plasma and tumor tissues drug
concentration may be required. We have studiecl the drug
carrier property of albumin microspheres containSng fiuoroura-
cil (5-[FU) [7･-9]. In this experiment we wish to dctermine the
unchanged 5-FU level in aqueous biological n}aterials. The
a･ssa>' using radioactively-labeled clrug [7, 8J and k>ioassay using
antirtiicrobial of 5-]IIrU [4] must interfere very little "'ith the
endogenous substances and have good sensitivity. But the
estimation of drug amounts with these/,Ip,ethods shows varia-
bility due to metabolism and lacks specifAy, while the spectro-
photometric assay [l] and the chroma77tographic analysis of
TLC [3] and GLC [5] etc. a!'e convenient methods but lack the
$ensitivity and rapidity needed for assay of 5-FU, l'herefore
these dctenniRation methods are not suitable to monitor the
bloed and ethcr1ody fluid colicentrations of this drug so as
to rationalize the dose scheclule for cancer patients. Biophar-
maceutical studies of this drt;g ha,ve been hampered by the lack
of a suitable chemical assav.                        "Recently, De Leenheer and co-workers [2] reported a spectro-
photometric determination which is comparabiy sensitive to
free 5-FU. As 5-FU is insoluble in chloroform, ethylether and
other organic solvents, the isoiation of 5-FU from aqueous bio-
Iogica1 materials into an organic solvent is difficult. But they used
the phenumena that 5-FU was amonoanion at pH ---- lO and might
be extracted from qqueous solution with quaternary alkyl
ammonium jons into an organic solvent as the ion-pair, and
then overcame the difficulty that 5-I?U is only slightly extrac-





[C' H3<CH2 )4]a Fi `
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In their method, hoxvever, "'hen the ion-pair complex "'as ex-
tracted into an organic solvent, they used a glass colunm-
packed cellulose. And this adsorbent must be purified in a
column by vvr sh ng with ethanol and dichloromethane until
the absorbance of the eluate at 269 nm was constarit at O.OiO.
These procedure and column extractiorf/somewhat curnbersome
and time-consuming. XVe thereiore deStmped a more rapid and
equally sensjtive method a determination of 5-FU in some bio-
logical samples by modifying their method.
2. Results and Discttssion
5-FU is slightly sol'uble in water (solubility = l2.EO n}g/ml at
25 OC [6]) and a diprotic acid (pKai =: 8.e ± O.1, pKa2 = ]3.0
 L O.l [6]). As it is insoluble in many organic solvents, it is
impossible to extract free 5--FU from an aqueous biological
system into some organic solvents. But monoanion species of
5-FU [1] form a 1:l ion-pair complex "rith tetrapentylammo-
nium monocation [2], and the complex may be extracted into
organic so!vents. Because the spectral propertie$ of the ion-
pair in the organic phase wer-e not accurate, a back extraction
was performed with a buffer solutioR which included a much
stronger ion-pair former, CI04m. At this time all 5-FU originally
present as ion-pair in the organic phase froms monoanionic ion
and may be quantitatively transfered into the aqueous phase. At
the same time, the quaternary a,mmonium cation forms aii
ion-pair complex with a perchlorate an.ion and is stable jn the
organic solvent. 5-FU anion xKrhich is back extracted into the
buffer !ayer gives good spectral properties at 269 nm.
In this assay it is important to adjust pH in the biologica}
sample to IO, If he buffer capacity is weak ancl the pH ui'
sarnple addecl to the buffer solution is not 10, then the ionic
strength of the buffer selution must be increased.
In this determ nation, 5-FU may often be obscured by en(lo-
genous subs nces. If high blank values were obta,ined, then
deproteinization should be caxTied out. The detailed precedure
is as follow: ORe ml of biological sample <sample containing
O-100 ng 5-FU) was put into a centnfuge tube, l ml of NaOH
(2 mol!l) and I ml of 10% zinc sulfate solution were added and
the prot in was denaturated. Then after this sample was neu-
ralized with } ml of 10% phospheric acid and centrifuged, 3 nii
of the supernatan  wa  used for the determination of ion-pair
method. If hydrochloric. acid was used as the neutral.ization
reagent, 5-FIJL was not extracted into an organic phase. If
trichloroacetld.c..,<iPCA) viras used as the deproteinization reagent,
5-FU was no i"{S5ctracted b cause the chloride anion and TCA                  ,anion form an ion-pair complex stronger than the 5-FU anion
with  quaternary ammonium cation. It appearpttgfrem these
facts that it is not suitable to use hydrochloric acid as the neu-
traiization reagent and TCA as the deproteiniza,tion reagent.
H molysis and rem ining blood affect the absorbance of a
blank and the sensitivity of this analysis. In collecting blood
samp es, he olysis should be avoided and in extraction of some
organ tissues, the blo d remaining in tissues should be cleared.
After the mice were $acrified by decapitation and as much
blo d s possib}e in the body was drawR out)the tissues should
be extracted. Their extracted samples should be washed we!l
with O,9% NaCl solut on, A deproteinization procedure may
be effective against the hernolysis and remaining b!ood, but
the sensitivity may be reduced by increasing the reagent vo-
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lume. If a biological sample contain$ much remainjng bloo(l,
t')'-FU in the sample can not be determined due to l}igh absor-
bance of the blank.
Linear stanclard curves (Fig. I) were prepared corresponding
to 5-FU concentrations from zero to leO I`g/ml in aqueous solu-
tion; then plasma and liver samples were obtained and used
to determSne the drug levels of samp!es in this concentratien
range after accounting for any dilution changes. The plasma
blank is almost zero tire same as the aqueous solution. A blaRk
value of the tis.sue samCL`p' le is not negligible, but this value is
constant in many samples, As to the sensitivities of plasma and
tjssue samples, they are similar to as aqueous sQlution as show･n
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Fig. 2. Piasn!a and tissues concentration of 5･fiuorouracil in mice given a single inlcction
of 1･25 g/kg- A: plagnia, B: tissues-kidney (1), !ung (2), liver {3>. Each point was determined
alter a mouse was sacrified at 5, le, 3e, and 6e znin. BlatLks of plasma grr tissues were oe-
tained from am uii-trcated mouse Vi ab-                                              A"q
l56
i.n3i./i.g"/S,gpi,k.li,gP/IC:aft/Si[,i.'i,it,/O,"fg,g.i,iil.){C/,lg'/e,i/O,(/1,i.+tS,e6L,W.algi,･iZ2d6ge,g,2brg,'t;gs,tts,is
This analytical procedure is a specific methOd fOr 5-FU, and i,
//8gi8,O,b.Zti{].C, kdh,¥V-i,':･,S,III8,g･abbi,O'igeg,',l}X.d,,`}ilSFuiS.S.O.g,axig.eeg
lg,fx}(a.n,l･hm,,a,n,¥ga,zt.s:･3.dg.Ogaf.e,20,rLilZ.9".d.O,Rehl･,b19i,Rg,i83is,ae.,R-.
venient for a reutine assay of 5-FU as clinical studies in caneer
pati ts.
3. Experimental
3.1. Cltcm21cals and Reagen･ts
5-FU "'as supplied from Kyowa Hakko Co., Ltd, and tetrapentyiammoni"rn
iodide xvas obtained from Eastman Kodak Co., Ltd. Tetrapentylammonium
counterion was prepared by the method described by De Leenheer and co.
svorkers [2] with a slight modification. A]I of the other chemibals xvere of
reagent grade and without further purification.
J･2r lon-Pair Extract･i･on MetJ;oa
Each l nil of biological material (sec 3,3.) was put iiito a IO nil glass-stoppe.
red centrifuge tube, and O.2 ml of concentrated carbonate buffer (e.62s mol/
l), p}E[ = IO and ionic strength 2.5, and l ml of tetrapentylammonium coun.
terion were successively added and then shaken. Then 5 ml of CH2Cl2 "tas
added and shaken for le min. After centrifugation, 4 ml of the organic ]ayer
was pipetted off and shaken for IO min with 5 ml of NaCI04 (O.2 mol/i> in
carbonate buffer (e.025 moll]), p}l = IO and ionic streng}}+-O.l. The eoncen-
tration of the buffer layer "'as determined spectrophotomlst/rical]y at 269 nm
by a Hitachi Type lOO-20 spectrophOtOMeter･ /.e{Nl
tg.3. Plasm,a ana Tissue SamPle PreParat?on
5-FU i.25 g/kg solution prepared by dissolvli}g the dru." in trisamkiome-
tliane (O.7 mo]/I) ssras injected into the ICR. mouse through tl}e tail vei",
and the mice Nvere sacrified by decapitation at certain time intervals; O,5 m]
blood and some tissues (liver, kidney and lung) were removed. rhe b)ood
sample was quickly transfered into a le ml centrifuge tube prevSously con-
taining l ml of 3.8% sodium citrate solution, and p]asrna was co]lected in
the usual way. After each tissue was washed quickly in O.9% NaCl solution,
these samples were homogenated "'ith nine or nineteen times as O.9% NaC}
solution as a tissue weight by IPotter-Elvehjem hon}ogenizer. The 10 or 5%
l,l9.Ig'`Z,ea,e,"daig,iX.g$.(ec51.;ri,f.Utg,e,d,til.ll.tOOO rPni for iO min; i mi of supernatant
             "
              c
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        To examine the possibility of utilizing aibumin microspheres as drug-carriers, an in
vitro release of S-fluorouracil (5-FU) from albumin microspheres was examined and the effect
                       rug-carrying microspheres olt Ehrlich ascites carcinoma in miceof intraperitoneally injected d
was studied. In vitro release characteristics determined by dialysis experiments showed that 5-
FU release continued over one week. We also Roted that drug release in the peritoneum of
ascites-bearing mice continued over one week and that their life-span increased. Furthermore,
the microspheres were phagocytized in vivo by the ascites cells. Our results suggest that
albumin microspheres containing 5-FU may represent an effective system of                                                              delivery                drug
with prolonged action.
       Keywords aibumin microsphere; drug-carrier; 5-fiuorouracil; prolonged ac-
tioR; phagocytosis; tumor celi
  Inert carriers have been used in chemotherapy
to direct drugs to target tissuesi) and they have also
been utilized to sustain the release of phar-
maceuticals.2) Miller et al.3> showed that polylac-
tate and polyglyconate copolymers were degraded
gradually after intraperitoneal injection into rats,
and they suggested that the polymers were useful as
drug carriers. Arakawa et aL`) reported sustained
drug release from liposome suspensions
(phospholipid vesicles) and Gregoriadis et aL5'6)
suggested that Iiposome-entrapped drugs were
phagocytized preferentially by tumor tissues. These
experiments showed the liposome to be an effective
drug carrier in cancer chemotherapy. Albumin
microspheres have been utilized as a lung or liver
scanning agent.7'8) Kramer suggested the
possibility that albumin microspheres could be
utilized as effective, tissue-specific drug carriers,9)
and he and his coworkers reported that human
serum albumin microspheres containing 6-
mercaptopuriRe were selectively phagocytized in
vilro by HeLa and glioblastoma cells.iO}
  W cently reported that 5-fluorouracil (5-FU)
entrapped in bovine serum albumin (BSA)
microspheres was present in high levels in the liver
of m ce after intravenous injection.i'> But it is ob-
scure that albumin microspheres may represeRt
thefapeutic effec  with prolonged action in cancer
chemotherapy. If albumin microspheres coRtamtng
antitumor agent show the sustained release and
prolonged action, then albumin inicrospheres may
provide a new field in cancer therapy. Then we
study the sustained release of BSA microsphere-
entrapped 5-FU and the prolonged action of the en-
trapped drug in Ehrlich ascites carcinoma as a
mod l tumor in viv.o. This preliminary study was
undertaken to determin  the extended action of the
micr6sphe es,' to measure the sustained release of
5-FU froin microspheres, and to observe the
phagocytosis of microspheres by tumor ceil in viv.o.
Drug-carrierProPeTty ofMicrosphere
MATERIALS AND METHODS
   Malerinls 5-Fluorouracil (S-FU) was ob-
tained from Kyowa Hakko Co., Ltd. and bovine
seruin alburnin (BSA) from Seikagaku Kogyo Co.,
Ltd. ICR mice were used in all animal experiments.
Male and female ICR mice, weighing ap-
proximately 30 g were intraperiteneally inoculated
at 1O-day intervals with 2×107 Ehrlich ascites.
 Preparatlon of asA Microspheres BSA
microspheres containing the antitumor agent S-FU
were prepared by a modification of the method of
Scheffel el aZ8) The finai inicrospheres contain
about 3.3% 5-FU.
  in Vlilro Drug Release Drug release from
the microsphe es was determined by a dynamic
dialy is system with a cellulose tubing (36/32,
Visking Co.) (Fig. 1). One hundred milligrams
BSA microspheres containing 5-FU were suspend-
ed in isotonic phosphate buffer (pH 7.4). After 1O
min ultrasonication using a 2.6 cm titanium probe
at 250 ptA in a sonicator (Nihonseiki Seisakusho,
Model G50022-4) and centrifugation to remove
the drug which adhered to the microspheres, the
precipitates were resuspended with 3 ml of isotonic
phosphate buffer (pH 7.4) and dialyzed against of
47 ml of isotonic phosphate buffer at 370. The in-
ner solu on was stirred at 50 rpm with a stirrer at-
tached to aR electric motor and the outer solution
was stirred at 200-300 rpm with an acrobat
stirrer (Emuesukiki Co., Ltd.).
  Samples (1 ml) were withdrawn from the outer
sollltion at certain intervals and 1 ml ef buffer was
added to ke p the volume constant. Drug ad-
sorption to the Visking dialysis tube was negligible.








mlcrosphere suspension (3 ml)
cellulose Visking tubing
pH 7.4 buffer solution (47 ml)
370 water
FIG. 1. Amparatus used to Study lhe Release of 5-
 FUfrom M cr spheres
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      i mined at 266 nm by a spectrophotometer (Model
 100-20, Hitachi Co., Ltd.) after the addition of
acetate buffer (pH 4.7).i2>
  [Tbxicity Sludies Toxicity of the "micro)
spheres contain ng 5-FU was determined by animal
survival and ev dence of rejection in 30 g male mice
following intraperitoneal injection. Acute (7 days)
and chronic (30 days) evaluations of the toxic ef-
fects were performed in 20 mice per group.
 , Microscopid ludy of Phagoaylosis
Phagocytic uptake was determined as foilpws: 24
hr after 2×107 ascites inoculation, the mice
received an intraperitoneal injection of microsphere
(30 mg of micr sphere containing 1 mg of 5-FU
pe  mouse) or 0.9% NaCl solution (control) and
were killed by cervical dislocation 5 days after
oc lation. The ascites cells were collected im-
mediately, fixed in methyl alcohol, staiRed with
Giemsa, and exarr}ined under an optical
microscope. Altematively, dehydration, drying
and metal-coat ng of the ascites were carried out,
and theR the samples were used to take scanning
electron micrographs.
 In vavo Drug Release To determine drug
release in the peri oneum and phagocytic uptake by
Ehrlich scites carc oma, 24 hr after inoculation
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FIG. 2. Release of5-FUfrom Microspheres
   Albumin microspheres prepared al 180O ( @?,
 1500 ( pt ?, 1 000 ( A?.
S52 K.Sugibayashi, et al,
microspheres containing 5-FU (30 mg ot
microspheres containing 1 mg of 5-FU per mouse).
free 5-FU (1 mg per mouse) or O,9% NaCI solutiQn
ccontrol). Changes in body weight and survival




  As shown in Figure 2, tnvitro 5-FU release
FIG. 3.




Microgmphs ofEh rlich Ascites Carcinoma
 controt, Cb) oflrer treatment with
ytized t!y tumor ce lls.
continued over one week, although the release rate
was very slow. The l vel of drug release depended
on the temperatuFe of the microsphere preparation.
suggesting difference in microsphere structures and
hardness lev ls. Zolle et al, 7) reported that swelling
occurred in microspheres suspended in a solution,
and that the degree of swelling decreased with in-
crease {n the temperature Qf the mic[osphere
preparation. An increase in the temperature of the














4. Scanning Electron Micrographs ofEhrfich Ascites Carcinema
ra ) cont-rot r ×6200V, (b) `ijCter treatme nt wiih afbumin microspheres containing 5-FU ( × 1 4000J,
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the microsph res, Ieading to decreased drug
r lease, Consequently, drllg diffuston in the
micfos here marrix is reduced due to decreased
microsph reporosityandincreasedtortuosity,
Microsphere Toxicity
   Negligible side effects were discovered in acute
and chronic toxicity studies. None of the 20 mice
examined in each type of study died even the
highest dosage tested (50 mg microsphere pef
mouse), No !ocalized uicerations and/or loss of
hair, indicative of feiection. were obsefved at
various dosage levels tested,
Phagoaytosis of MicrosPheres by Ehrlich Ascites
Carcinoma
  Figure 3 shows micrographs of Ehrlich ascites
carcinoma in mice 5 days after injection of albumin
microspheres or O.9% NaCl solution. Figufe 3b
reveals microsphere phagocytosis by the ascites
cells, Kramer and Burnstein,'O) using isotope-
labeled drugs entrapped in microspheres, demon-
strated the uptake of albumin microspheres by
tumor cells in vitro. Since the mechanism un-
derlying phagocytosis ef macromolecules and
microspheres has not been completely elucidated to
date, we attempted the additional demonstration of
the presence of microspheres in the cell lysate.
  Figure 4 shows that intraperitoneal ad-
ministration of albumin microspheres containing 5-
FU effected morphojogical changes on the surface
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FIG. 5. Chanse in Body VVei ht ofEhrlich Ascites
 Tumor Bearing Mice
   [Ileeatment with O, 9% NfClsotution ( c: 1, free
5-FU r Lfi, ? and icrospheres containing 5-FU r o ?
 notvnatcontrolbearingnotamorreJ
O.9% NaCl sollltion. This change may be explained
by a sustained abdominal level of 5-FU, by an in-
racellular concentration of 5-FU due to the en-
docyti  activity of the tumor cells or by both effects.
EOIect ofM crosPheres Containing 5-FU on Eh rtich
Ascit s
  AIthough 5-FU has been follnd to be active
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FIG. 6, opcl ofAlbumin MicrospheTe-entrapped 5-FU on th
 Ascites Carcinoma
   Zhe 1ijlr span was increased by 1,2% in 5-FU treated
 inicrospherescontaining5-FU,
 "This valve represents the average of9 mice,
20 24
e Surviva/. of Mice inoculated with Ehrlich
mice and 20.5%' in mice administered
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poor due to a fast elimination rate. We further
examined the effect of microspheres containing 5-
FU in Ehrlich ascites and found that intraperitoneal
injection of albumin microspheres containing 5-FU
resulted in drug activity against the ascites and the
suppression of tumor growth at the inoculation
site, lasting for approximately one week. Thereaf-
ter, however, tumor growth effected an increase in
animal body weight (Figare 5). The increase in life-
span effected by microsphere treatment is showR in
Figure 6.
 DISCUSSION
    Zolle el aL7) and Scheffel el al8) utilized the
 phagocytic activity of the liver and spleen and
 radiolabeled albumin microspheres to study and
 diagnose the function of the reticuloendothelial
 system. AlbumiA microspheres were degradated
 and metabolized and no evidence of antigenicity
 was found, indicating the effective drug-carrier
 properties of microspheres. We reported earlier that
 microspheres injected intravenously into mice were
 concentrated in the liver due to phagocytosis of the
 reticuloendothelial system.ii i4}
    In the present study we found that in vilro
 release of 5-FU from aibumin microspheres con-
 tinued over one week (Figure 2). Our findings that
 after microsphere injection, the average body
 weight of the ascites-bearing mice did not increase
 for one week, indicate that sustained drug release
 occurs iR the peritoneum and that effective drug
 concentrations may be rr}aintained for a week
 (Figure 5). We also noted a prolongation in the life-
 span of tumor-bearing mice following therapeutic
 microsphere admiRistration (Figure 6). Our ex-
 perimental results suggest that albumin
 microspheres containing 5-FU may represent an ef-
, fective system of drug delivery with prolonged ac-
 tion.
    However, suppression of tumor growth disap-
 peared by one week. This may be due to the fact
 that the amount of 5-FU delivered in siRgle-shot
 administration of microspheres was therapeutically
 insufficient.
   Studies are presently under way in our
 labolatory to examine the effects of multiple dose
K.Sugibayashi, el al,
dmi istration o  microspheres contaiRing 5-FU. In
addition, we pl n to investigate the applicability of
the microsphere drug de ivery system to several ex-
perim ntal umor systems.
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THE STUDY ON THE BIOLOGICAL FATE OF PARABEN AT THEDOSE OF PRACTICAL USAGE IN RAT. I. THE METABOLISM ANDEXCRETION OF ETHYL p-HYDROXYBENZOATE (ETHYLPARABEN) AND p-HYDROXYBENZOIC ACID*
4
HIROSHI KIWADA,**i SHOJI AWAZU,'"2 AND MANABU HANANO
fucudy ofItharmaceutical Sttences, [TZee Univemsdy of 7-bdyo, 7-3-1 Hongo Bun,(lyo-ku, Tblpo 113,
foPan
(Received March 13, 1979)
       The biological fates of ethylparaben (EP) which has been widely used as a preser-
vatives for the pharmaceutical preparations and foods, and p-hydroxybenzoic acid (HB)
which is the parent compound of EP, were investigated at the dose of practical usage (2
mg/kg) in rats. Although both EP and HB were metabolized to glycine conjugate (Ml),
ester type glucuronide (M3) and sulfate (M4) of HB and excreted in the urine and bile, the
excretion ratios were different as compared with the results of higher dose experiments
carried out by other authors, and a route dependency was also found in the rate of excretion
in the bile.
       The excretion data obtained in this study are shown as follows: In intravenous ad-
ministration of EP, the excreted total activity was 91.3% per dose in the urine and 5.97% in
the bile, and percentages per dose of the major metabolites excreted in the urine were 8.14%
of HB, 39.6% of Ml, 29.5% of M3 and 6.48% of M4. In intraduodenal administration of
EP, the excreted total activity (83,5%) and the activity excreted as HB (3.51%) decreased
compared with the intravenous administration.
       In the HB administration, the route dependency of the total activity was not fouRd,
but a decrease in the excretion of HB in the intraduodenal administration was found.
       The excretion of total radioactivity almost ceased by 5 hr and the biological half-
lives obtained from the B-phase of the sigma-minus plots of the metabolites excreted in the
urine were 40-70 min.
       The result obtained in this study differ from those of other a'uthors at the high dose
expenments.       Keywords biological fate; metabolism; excretion; paraben; ethyi p-hydroxybenzoate;p-hydroxy'benzoic acid i
  Alkyl p-hydroxybenzoate (paraben) has been
widely used as a preservative for pharmaceutical
preparations , foods, and cosmetics.
  Matthews el al, showed that parabems were safe
preservatives based on the study ifi the acute and
clinical toxicity.i) On the biological fates,
Tsukamoto et aL demenstrated that P-hydroxy-
benzoic acid (free acid, HB), p-hydroxyhippuric
acid (glyciR  conjugate of HB, Ml), p-
carboxyphenyl glucuronide (ether type glucuronide
of HB , M2), p-hydroxybenzoyl glucuronide (ester
type glucuronide of HB, M3) andp-carboxyphenyl
sulfate (ether sulfate of HB, M4) were excreted in
the uriRe of the rabbit after oral administration of
' This work was presented at the 98th Annual Meeting of Pharmaceutical Society of Japan, Okayama, April 1978.
" Present address: 1)fuculty ofPharmaceuticalStiences, Science U)7ivers. iip, of Tobyo, 12, lbhitgtzrya ,Fbemagewara-machiShin-
 iuku-ka, Tbdyo 162, fopan; 2? Tobyo College ofPharmaq3,, Hon'nouchiHlachioji, To,(uvo 192-03, fopan.
No. 10 3087
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Drug-carrier Property of Albumin Microspheres iR Chemotherapy. IV.i)
  Antitumer Efuct of SiRgle-shot or Multiple-shot Administration of
       Microsphere-entrapped 5-Fluorouracil oR Ehrlich Ascites
                     or Selid Tumer in Mice2)
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                           and Yosmo KATo
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   To examine the possibility of utilizing albumin microspheres containing 5-fiuorouracil
(5-FU) as a drug carrier, the antitumor activity of albumin microsphere-entrapped 5-FU
against Ehrlich ascites carcinoma and solid tumor in mice was studied. After intraperito-
neal injection of microsphere-entrapped 5-FU into Ehrlich ascites-bearing mice, the 5-FU
level in the ascites was very high compared with that after injection of the free drug.
The suppressive effect of microsphere-entrapped 5-FU on tumor growth in ascites-bearing
mice was significantly higher than that of the free drug. A'fter multiple-shot administra-
tion of microsphere-entrapped 5-FU to ascites-bearing mice, the increase in 1ife-span
was over 50% compared with a control. The therapeutic effect of microsphere-entrapped
5-FU on Ehrlich solid tumor after intratumoral injection was also studied. 5-FU level
in the tumors of mice was significantly higher after intratumoral injection of microsphere-
entrapped 5-FU than when the free drug was administered. The injection of microsphere-
entrapped 5 FU, which was slowly reieased from the a}bumin microspheres in the solid
tumor, caused a higher suppression of tumor growth at the inoculation site than admmi-
stration of the free drug at the same dose. These results suggest that albumin micro-
sphere$ containing 5-FU may represent an effective system for drug delivery, with pro-
longed action.
   Keywords albumin microsphere; drug carrier; 5-fiuorouracil; Ehrlich ascites
carcinoma; Ehrlichsolidtumor; prolongedaction; mouse
"
    The effective use of pharmacologically active agents is often limited by side effects on the
healthy tissue, incomplete transport to the desired site of action, and!or insu'Eficiently sustained
action after reaching the target tissue. Tl}is is particularly true in the chemotherapy o.f
cancer. One of the methods used to overcome these shortcomings is to employ non-toxic
and biodegradable drug carriers which direct drugs to the target tissues. From this poiRt
of view, various investigators have attempted to develop useful drug carriers, based on evalua-
tion by in vitro and in vivo experiments.4) The use of liposomes has been extensively iRvesti-
gated by Gregoriadis et al.5> aRd their potential as carriers for pharmaceuticals in viwo seems
clear. Kramer suggested that albumin microspheres, which have been used as a lultg or liver
scanning agent,6) might be utilized as vehicles for achieving specific drug delivery,7> and he
1) Preceding paper, Part III: K. Sugibayashi, M. Al<imoto, Y. Morimoto, T. Nadai, and Y. Kato, J. Pharm.
  Dyn., 2, 350 (1979).
2) Part of this work was presented at the 99th Annual Meeting of the Pharmaceutical Society of Japan,
  Sapporo, Aug., 1979.
3) Location: 1-1 Keyakidai, Sakado, Saitama, 350-02, Japan.
4) G. Gregoriadis, Nature (London), 265, 407 (1977).
5) a) G. Gregoriadis, F-EiBS Lett., 36, 292 (1973) ; b) G. Gregoriadis, C.P. Swain, E.J. Wills, and A.S. Tavill,
  La7zeet, 1974, 1, 1313 (1974); c) G. Gregoriadis, G. ])apergolas, and E.D. Neerunjun, Bioohem. Soo.
  T7ans., 4, 256 (1976).
6) a) I･ Zolle, B.A. Rhodes, and H.N. Wagner, Jr., lnt. J. APPL Raaiat. fsotoP., 21, 155 (1970); b) U･
  Scheffel, B.A. Rhodes, T.K. Natarajan, and H.N. Wagner, Jr., J. Nucl. Mea., 13, 498 (1972)･
7) P.A. Kramer, J. Phewm. Sci., 63, 1646 (1974).
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and his co-workers reported that human albumin microspheres containing 6-mercaptopurine
were phagocytized by several tumor cell lines.8)
    We also have been studying the utility of albumin microspheres as drug carriers which
might localize antitumor agents in target tissues. In previous studies, an enhanced accumula-
tion of 5-fiuorouracil (5-FU) entrapped in bovine serum albumin (BSA) microspheres vLras shown
in mice.9) Further, it was found that the injection of 5-FU after its entrappment in micro-
spheres prolonged the survival of Ehrlich ascites-bearing mice to a greater extent than did a
similar amount of free 5-FU.i)
    The present study was undertakeR to investigate the antitumor effects of 5-FU entrapped
in albumin mi.crospheres after single-shQt or multiple-shot administration, using Ehrlich
ascites and solid tumors as model tumors in vivo.
Experimental
   Materials 5-Fluorouracil (5-FU) was obtained from Kyowa Hakl<o Co., Ltd. and bovine serum albu-
min (BSA) from Seil{agaku Kogyo Co., Ltd. 5-Fluorouracil-6-3H (3H-5-FU) and i25I-human serum albumin
(i25I-HSA) were purchased from the Japan Radioisotope Association. Pronase (1.17×106 trypsin unit/g,
Kal{en Kagaku Co., Ltd.) was selected as a protease.
   Preparation ofBSA Microspheres BSA microspheres containing 5-FU were prepared by a modification
of the method of Scheffel et ag.6b> The drug content of the final product was O.033 mg/mg.
   Iit Vitro Drug Release Drug re!ease from microspheres was determined by means of a dynamic
dialysis system employing cellulose tubing. The procedure was described in detail elsewhere.i) The effects
of hydrolytic enzymes on the in vilro drug release were determined by adding protease (1 or 15 mg) or lyso-
semal fraction (1 mg) to the inner solution (pH 7.4 phosphate buffer containing 150 mg of microspheres)
from the cellulose tubing. Lysosomal fraction was isolated from freshly collected Ehrlich ascites ceils in
O.25M sucrose solution by a modification of the method of Lewis et al.ZO>
   in Yivo Experiments Male ICR mice, weighing approximately 30 g, were used, and the dose of
5-FU was O.5 mgfmouse.
   In the first series of experiments, mice were intraperitoneally inoculated with 2×10' Ehrlich ascites
cells. Five, 7 and le days after inoculation, the volume of the ascites and the number of tumor cells in the
ascites were determined in mice treated with O.25 ml e£ microsphere suspension, free 5-FU er O.9% NaCl
solution as a control 24 hr foilowing tumor cel! inoculation. Viable tumor cells in the ascites were counted
microscopically with a Thoma counting chamber, with trypan blue staining. Furthermore, O.25ml of
i25I-labelled alburnin microsphere suspension containing nonlabeled 5-FU, nonlabeled albumin microsphere
suspension containing 3H-5-FU or non-entrapped (free) 3H-5-FU so!ution was injected intraperitonealiy
7 days after inoculation. Aninnals were sacrified at interva!s and ascites fiuid was collected to detexmine
the 5-FU and microsphere levels in the ascites.
   In the second series of experiments, 1, 5 and 9 days after intraperitoneal inoculation with 1 × 10g ascites
cells of the tumoer, the mice were injected intraperitoneally with O.25 ml of microsphere suspension, free
5-FU or O.9% NaCl solution. Changes in body weight and survival times o£ treated, tumor-bearing mice
were recorded.
   The third series of experiments was carried out to assess the antitumor effect of 5-FU given in micro-
sphere form on Ehrlich solid tumor, A suspension of 2 × 10' ascites ceils of the tumor was subcutaneously
imp!anted into the scapular region of mice. Direct injection into the solid tumor of about O.15 m} of 5--FU
entrapped microsphere suspension, free 5-FU or O.9% NaCl solution was done at 1 day for a single-shot
administration or at 1, 5 and 9 days for multiple-shot administration after tumor implantation. Daily
measurements of tumor size were taken with caMpers. The maximal perpendicular dimensions (mm) of a
tumor were averaged and the volume was evaluated on the base of a radial tumor cell distribution. Further-
more, the levels of 5-FU and microspheres in each tumor at various times foliowing administration were
determined. The procedures were as same in the first series of experirnents on ascites cells.
   Analytical Methods To measure 5-FU and microsphere levels in the ascites or solid tumor, each tumor
was collected. Each aliquot of tumor was mixed with the same amount of e.9% NaCl solution, homogenized
and centrifuged for 10 min to produce a supernatant. For measurement of tritium level, the supernatant
was treated with a Protosol (New Engiand Nuclear)-ethy･1 alcohol solution (1 : 2) and diluted directly with a
scintillator (Aquasol II, New England Nuclear), then the radioactivity was determined with a liguid scintilla-
 8) P.A. Kramer and T. Burnstein, L2Llig Sci., !O, 515 (1976).
 9) a) K. Sugibayashi, Y. Morimoto, T. Nadai, and Y. Kato, Chem. Pharm. BulJ., 25, 3433
   Sugibayashi, Y. Morimoto, T. Nadai, Y. Kato, A. Hasegawa, and T. Arita, ibia., 27,




tion counter (LSC-651, Aloka Co.). For measurement of microsphere level, the radioactivity of i25I-labeled
microspheres in the tumors was determined with an auto-gamma scintillation spectrometer (type 5110,
Packard) .
ResultsandDiscussien
(1) Effkict ofHyd oly ic Enzymes on the Release ef5-FU from Micrespheres
    The in vitro release of 5-FU from albumin microspheres continued for over one week,
as shown in a preceding paper.i> The effect of hydrolytic enz>maes on the release of 5-FU from
micr spheres is show  in Fig. 1. The addition of lysosomal fraction to a microsphere suspen-
sion resulted in a small increase in the amount of drug release, and the addition of a protease
(Pronase) resulted in a large increase. This increase may be due to digestion of albumin micro-
spheres by the hydrolytic enzymes. This suggests that microspheres taken up into tumor
cells by endocytosis could be digested by a Iysosomal enzyme.
    We have already suggested that 5-FU entrapped in albumin microspheres shows prolonged
action again t Ehrlich ascites carcinoma in mice,i) and this may therefore be due to sustained
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Fig. 1. Effect of Hydrolytic Enzymes on
 the Release of 5-FU from Albumin Mi-
 crospheres
 Treatment with 1 mg (A) or 15 mg (A) of protease,
 1 mg of lysosomal fraction (O) or buffer only ([I]).
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  67 89 10 56789 10    tumor inoculation after tumor inoculation
   Effe ts of Free Albumin Microsphere-
entrapped 5-FU on the Ascites Volume and li)hrlich
Ascites Tumor Cell Count in Mice
 Treatme t with O.9% NaCl solution (O), free 5-FU (A) and
microsphere- nt apped 5-FU (B)-
 Re lts are expressed as the means±S.E. of 5 mice.
(2) Efliect of Microsphere-entrapped 5-FU on the Grewth of Ehrlich Ascites Cells
    U on intraperitoneal administr tion of free and microsphere-entrapped 5-FU to mice
inocu!ated with Ehrlich ascites cells, the survival time of rr}ice treated with the microsphere-
entrapped drug is longer.i) In this work, we studied the effect ef microsphere-entrapped
5-FU on the production of ascites fluid and cell counts to confirm the therapeutic effect of the
drug entrapped in albumin microspheres. The elimination rates of free and microsphere-
entrapped 5-FU from the injection site, and the biodegradation of albumin microspheres
after injection were also estimated.
   Following inoculation, the viable cell counts and the ascites volume increased proportionally
(Fig. 2). The viable cell counts after treatment with microspheres were significantly different
frorn that for O.9% NaCl solutioR (Student's Vtest: 5 days, P<O.OOI; 7 days, P<O.05; 10 days,
P<O.02). However, a gToup treated with free 5-FU was not different frora NaCl solution
a one (5 days, P<O.Ol;7 and 10 days, no significance). These results suggest that, in the
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treatrnent of tumor-bearing mice, 5-FU entrapped in microspheres may, under certairi
conditions, be superior to non-eRtrapped 5-FU because of the sustained release of 5-FU
from the albumin microspheres.
    The time course of microsphere and 5-FU levels in the ascites are presented in Fig. 3i
which shows the elimination of radioactivity due to i25I-labeled microspheres and 3H-5-FU
in the ascites. The metabolism and elimination of non-entrapped 5-FU were fast, and the
percentage of tritium radioactivity remaining at 24 hr after injectioit was only O.93% of the
dose. The percentage of tritium radioactivity released from microspheres and rentaining
in the ascites was 2.46% at 24 hr and IJ.31% at 48 hr after injection of microsphere-entrapped
5-FU. In contrast, the loss of albumin microspheres from the injection site at 24 hr after
injection was extremely small. These data suggest that the biodegradation of albumin micror
spheres in the ascites is very slow. 5-FU which is slowiy released from the microspheres is
more effective against the Ehrlich ascites cells; the rate of multiplication of Ehrlich ascites
cells was clearly lower in the presence of microsphere-eRtrapped 5-FU than non-entrapped
5-FU.
(3) Effect of Multiple-shot Administration of Microsphere-entrapped 5-FU on Ehrlich AsciteS'
    When microsphere-entrapped 5-FU was intraperitoneally injected 24 hr after inoculation
with Ehrlich ascites cells, the life span was increased by 20.5% compared with a control (O.99i(g
NaCl solution).i) In the above experiments, however, suppression of tumor growth ceased
after one week, presumably because the amount of 5-FU delivered by single-shot administra;
tion of microspheres was therapeutically insufficient by one week after administration. We
therefore examined the effects of multiple-shot administration of microsphere-entrapped 5-FU,
on the tumor growth. Figs. 4 and 5 show the changes in body weight and survival of mice
after injection with the microspheres 1, 5 and 9 days after inoculation with Ehrlich ascites
carcinoma. The increase in body weight after administration Qf the microspheres was signifi-
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Fig. 3. 5-FU and Albumin Microsphere
 Levels in Ascites Fluid after AdmiRi-
 stration of Free or Microsphere-entra-
 pped 5-FU
 Free 5-FU (O), 5-FU released from microspheres
 (e), microsphere level ([]).
 Results are expressed as the means±S.E. of 3
 mice.
11) Microspheres!O.9% NaCl solution, P<O.05, 9 days
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Fig. 4. Change in Body Weight of
 Ehriich Ascites Carcinoma-bearing
 Mice after Multiple-skot Admini-
 stration of Free or Albumin Micro-
 sphere-entrapped 5-FU
 Treatment with O.9% NaCl solution (O), free
 5-FU (A) and microsphere-entrapped 5-FU
([])i
 Each point represents the average of 10 mice.
 Arrows indicate the a(iministration of iree or
 albumin microsphere-entrapped 5-FU.
follow ngin culation; microspheres/free 5-FU,
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effect of multiple-shot administration of microsphere-entrapped 5-FU was superior to that
of multiple- hot a ministration of free 5-FU. Survival time was also improved from 20.5%
for single-shot administratioR of the microspheres to 52.0% for multiple-shot administration.
T se results indicate that multiple-shot administration of albumin microsphere-entrapped
-FU may be effective in cancer chemotherapy.
(4) Effect of Single--shot or Multiple-shot Administration ef Micresphere--entrapped 5-FU on
Ehrlich Solid Tumor
   The effect of entrapp d 5-FU on Ehrlich solid turnor was studied. Fig. 6 shows 5-FU
levels and rad activity due to i25I-labeled microspheres in the solid tumors after injection of
fr e or microsphere-entyapped 5--FU into solid tumor-beariBg mice. Solid tumor cells are
not mobile and the R oplasmic tissue is rigid, so the disappearance of 5-FU from the solid tumor
sh uld be slower than that from the ascites. In the solid form, the eiimination of tritium
radioactivity of 5-FU was appa ently retarded by slow release of 5-FU from albumin micro-
spheres compared with that of free 5-FU. The results indicate the utility of intratumoral
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Fig. 5. Effect of Multiple-shot Administration of
 Free or Albumin Mic o phere-entrapped 5-FU
 on the Survival of Mice Inoculated with Ehrlich
 Ascites Carcinoma
  Twe out of 10 mice given albumin microsphere-entrapped
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        Time after injection (hr)
Fig. 6, 5-FU and Albumin Microsphere
 Levels in the Tumor after Administra-
 tion of Free or Albumin Microsphere-
 entrapped 5-FU
  Symbols: as in Fig. 3.
  Results are expressed as the means±S.E. of
  3 mice.
stM48
    Fig. 7 shows the effects of free and microsphere-entrapped 5-FU on the growth of
Ehrlich solid tumor. Nearly all mice iR the groups administered O.9% NaCl solution or free
5-FU had gross soiid tumor invelvement. Microsphere-entrapped 5-FU, however, was rather
active against the solid tumor, and the tumor size became about 115 at 10' days and about 1110
at 20 days after tumor inoculation compared with other groups receiviRg O.9% NaCl solution
o  free 5-FU. This suppression of tumor growth at the inoculation site may be dependent
on the prolonged release of 5-FU from the albumin microspheres.
    Furthermore, we studied the effect of multiple-shot administration ofmicrosphere-entrap-
ped 5-FU on the Ehrlich solid tumor. Marked suppression of tumor growth at the inoculation
site was observed on administering miGrosphere-entrapped 5-FU. This antitumor activity
was surprisiRgly strong compared with single-shot administration of microsphere-entrapped
5-FU to the solid tumor (Fig. 8).
   The experimental results in this paper show the antitumor effect of albumin microsphere-
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Fig. 7. Effect of Single-shot Administra-
 tion of Free or )v([ierosphere-entrapped
 5-FU on the Growth of Ehr!ich Solid
 Tumor
  Symbols: as in Fig. d.
  Each point represents the average of 10 mice.
  The arrow indicates the administration of free
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        Days after tumor inoculation
Fig. 8. Effect of Multiple-shot Admini-
 strati  of Free or Microsphere-entrap-
ped 5-FU on the Growth of Ehrlich
 Solid Tumor
  Symbols: as in Fig. 4.
  Each PoiRt represents the average of 10 mice.
  Arrows indicate the a(iministration of free or
  albumin rnicrosphere-entrapped 5-FU.
l
carcinGma and solid tumor. Further, t'reatment by multiple-shot administration of micro-
sphere--entrapped 5-FU was particularly effective.
    This result may be explained in terms of the sustained release of 5-FU from albumin
micrespheres in vivo. 5-FU has been used clinica!ly for the treatment of varjous tumors by
parenteral administration,i2> because oral administration of this drug shovtrs higher toxicity
than parenteral administration.i3) It seems lil<ely that 5-FU entrapped in albumin micro-
spheres shovgTs pronounced antitumor activity and low toxicity.
    Studies are presently under way in our laboratory to examine the site specificity of the
drug and its prolonged action against experimental liver tumor after intravenous injection
of albumin microsphere-entrapped 5-FU.
   Acknowledgement Tke authors are grateful to Miss M. Igarashi for her help iB some experiments.
12)
13)
M.J. Cline, "Cancer Chemotherapy,') W.B. Saunders Co., Philadelphia, 1971, pp. 1-2e5.
R.G. Hahn, C.G. Moertel, A.J. Schutt, and H.W. Bruckner, Canoer, 35, 1031 (1975).
No. 5 1433
(,C,h(e,rgi,ggL'I,M,,･(?,U,1is]
Drug-carrier Property of Albumin Micrespheres in Chemotherapy.
     Antitumor Effect of Microsphere-teRtrapped Adriamycin on
             Liver Metastasis of AH 7974 Cells in Rats
V.1)
YASUNORIMoRIMoTo,* KENJI SuGIBAyAsHI, aRd YosHIo KATo
Faculty of Pharmaceutical
     Keyahidai, Sakado,
Seiences, losai University, 1-1
Saitama, 350-02, Jmpan
(Recoived January 13, 1981)
   Bovine serum albumin microspheres containing adriamycin were prepared by heat
solidification of albumin in albumin-adriamycin aqueous solution in cottonseed oil emul-
sions. The efficiency of the microspheres as a drug carrier of adriamycin was evaluated in
liver metastasis caused by the injection of AH 7974 tumor cells into the portal vein of rats
as a model of release of such cells into the vein during the course of surgical removal of
gastric cancer. Adriamycin entrapped in the microspheres exhibited sustained in vitro
release which followed firs"order kinetics. After intraportal injection in rats, the micro-
spheres and entrapped agent distributed mainly in the liver, and the disappearance rate
from the tissue was very slow in comparison with that of free drug. The survival times
of rats bearing AH 7974 Iiver metastasis were prolonged by intraportal administration of
microspheres containing adriamycin. In contrast, free adriamycin or microspheres
without entrapped drug did not significantly increase the Iife span over the control, These
results suggest that alburnin microspheres containing adriamycin may be applicable as a
                                       --drug carrier in the adjuvant chemotherapy of liver metastasis.
   Keywords albumin microsphere; drug carrier; adriamycin; sustained release;
preferential distribution; AH 7974 liver metastasis; antitumor effect; adjuvant chemo-
therapy
    One of the goals in cancer chemotherapy is directing drugs selectively into tumor tissues
to minimize the side effects on Rormal tissues. In the past, considerable efforts have been
directed toward the development of drug carriers, i.e. DNA complexes,2> liposomes,3}
and emulsions,4) able to deliver antitumor agents selectively into tumor tissues. We have been
studying the utility of albumin microspheres containing 5-fiuorouracil as a delivery system,
in the hope of enhancing the drug accumulation in the liver of mice after intravenous injec-
tion5,6> and obtaining proionged action against Ehrlich ascites and solid tumors.i,7) This
series of studies was undertaken to investigate the ability of antitumor agents entrapped in
albumin microspheres to prevent liver angiosarcoma or liver metastasis caused by the release
of tumor cells through the portal vein duriBg the course of surgical removal of gastric cancer.
    The present investigation demonstrates the antitumor effect of adriamycin-containing
microspheres on the liver metastasis in rats which had been injected with AH 7974 cells into
the portal vein.
Experimental
   Materials Non-labeled and 3H(G)-labeled adriamycin were from Kyowa EIakko Co., Ltd. Bovine
serum a}bumin (BSA) (Fr. V. Powder) was purchased from Seikagaku Kogyo Co., Ltd. and i25I-humalt
serum albumin from Japan Radioisotope Association, Cottonseed oil was selected as a vegetable oil. Non-
ionic surfactants, Span 85 and polysorbate 80 were obtained from Wako Pure Chemicals. All oth'er chemicals
were commercial reagent-grade products.
   Animals Male Donryu rats, weighing about 150g, were used in all animal experiments.
   Preparatien of BSA Microspheres The basic procedure of Scheffei et al.8) was modified for the prepara-
tion of albumin r}icrospheres containing adriamycin. A mixed aqueous solution containing leOmg of
adriamycin and 250 mg of BSA in a volume of 4 ml was emulsified into 100 mi of cottonseed oil containing
10% (vlv) Span 85 by the method described in a previous paper.6) The solidification temperature of albumin
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in oil emulsions was 170-1800. The average diameter and drug content of the finai product were about
1.44 ym and O.15 mgfmg,
   .in Yitro Drug Release Adriamycin release from microspheres was determined by rneans of a dynamic
diaiysis system employing cellulose tubing. The procedure was described elsewhere.') Adriamycin was
determined by fiuorescence intensity measurement at 470 nm (excitation) and 56e nm (emission)9) in a
Hitachi 65e-60s fiuorescence spectrophotometer.
   Procedure for Preparing Liver Metastasis AH 7974 cells were maintained by weekly transplantation
in ascites form in rats. For preparing liver rnetastasis, a rat was anesthetized by intraperitoneal injection
of sodium pentobarbital and the portal vein was exposed by a midline abdominal incision. AH 7974 ascites
cells (106 cells/O.1 ml) were implanted into the portal vein, and the bleeding after administration was stopped
by fingeur pressure. The abdomina! cut was sewn up, and chloramphenicol ointment (Sankyo Co,, Ltd,) was
applied to prevent infections,
   Microsphere and Adriamycin Distributions in Rats--i25I-labeled microspheres containing non-iabeled
adriamycin or non-labeled microspheres contain!ng 3H(G)-labeled adriamyc!n (2 mg of microspheres contain-
ing 300 pg of adriamycin) suspended in O.9% NaCl solution containing O.2% (v/v) polysorbate 80, er 300 ptg
of free 3E[(G)-adriamycin in O.9% NaCl solutioR was injected iRto the portiai vein or taii vein in rats. At
le min, 1 hr, and 1 day after administration, 1 ml ef blood was taken by heart puncture and each rat was
sacriftced by decapitation. Several tissues (heart, lung, spleen, kidney, liver, and intestine) were removed
and weighed wet. Z25I-labeled microspheres in blood and isolated tissues were determiRed with a Packard
5110 Auto-gamma scintillation spectrometer. Tritium levels in biood and isolated tissues were rneasured
with an Aloka LSC-651 liquid scintiliation spectrometer after combustion in an Alol<a ASC-111 sample
oxidizer.
   The amount of tritium released from the microspheres in the iiver (i.e., total tritium in the liver minus
microsphere-entrapped tritium) was deterrnined as follows. The liver was homogenized with 3 volumes of
O.9% NaCl solution, Two ml of homogenate was used for each determination. To each sample, 1 m! of
16.5% AgN03 solution was added as a deproteinization reagent. The tubes were shaken vigorously for 20
min then centrifuged at 1500 rpm for 10 min, and the supematant was subiected to liquid scintillation count-
ing after combustion in a sample oxidizer.
   2uenching correction was done by the external standard ratio method for tritium radioactivity. The
tissue distribution of radioactivity is represented as % of administered dose in whole tissue (blood) or per
gram of tissue (ml of blood).
   Effect of Drug-containing Microspheres on Liver Metastasis--The antitumor effect offree or entrapped
adriamycin against AH 7974 liver metastasis was studied in terms of animal survivai' (10 mice per group).
AH 7974 cells aione were administered into the portal vein in rats of the control group, Three hundred pg
of adriamycin or 2 mg of microspheres containing 300 ptg of adriamycin was co-administered with AH 7974
cells in the treated groups, and 2 mg of microspheres without entrapped drug was administered to 5 rats to
checl< the effect of the microspheres themselves on the tumor.
   The animals were housed in standard rat cages and observed for 60 days. The rnedian survival time
of treated rats against that of contTol rats (TIC%) was used as a measure of antitumor effect.
Results
    Figure 1 shows the in vitro release of adriamycin from a!bumin microspheres. It is clear
that, in contrast to the rapid release of free adriamycin from a Visking dialysis sac, the re-
               Time (days)










Release of Adriamycin from a Dialysis
O; free adriamycin,
@; microspheres containing adriamycin.
lease of adriamycin from microspheres and
through the Visking sac was small. The
half-release time of the free drug through the
Visking sac, Tso%, was about O.5 hr. The re-
Iease of adriamycin from microspheres fol-
lowed first-order kinetics for about four days
after the start of the experiment･ The half-
release tirne of adriarriyciR from micro-
spheres was about 7.3 days and the cumu-
lative amount released during 7 days was
42.5%. Entrapment in microspheres re-
sulted in a remarkable retardation of the
release of adriamycm･
   FigTtre 2 shows the distribution of 3H(G)-
adriamycin te various organS at 10min, 1hr,
g
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and 1 day a ter intraveno s or intraportal injection. When the route of administration was
changed from the tail vein to the portal vein, the distribution of adriamycin in the liver at
10 min after injection increased from 3.9%!g liver to 6.3%lg. Although the data are not
shown, the blood concentration after intraportal injection was lower than that in all tissues
measured in this experiments. After intraportal injection, the drug levels in the heart and
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Fig. 2. Tissue Distributions at 10 min, 1hr, and 1 day after Injection of Free
 3H(G)-Adriamycin
     El2Z22 ; intravenous injection,
     M; intraportal injection.
     Each column represents the mean value of 4-7 rats. Verticai bars indicate S.E.M.
   Figure 3 hows the distribution of i25I- and 3H-radioactivities after intraportal injection
of i25I-labeled micro ph res containing non-labeled adriamycin or non-labeled microspheres
containing 3H(G)-adriamycin. As i25I-radioactivity is rigidly bound to the microspheres,iO)
the distribution of !25I-radioactivity corresponds to the microsphere distribution in rats.
Since adriamycin is little metabolized,ii) the distribution of adriamycin entrapped in micro-
spheres and released from microspheres. These were named microsphere fraction (M) and
free fraction (F), respectively. At 10 min, 1hr, and 1 day after intraportal injection of i25I-
microspheres, the percentages of dose per grarn of liver were 13.9, 13.9, and 13.4., respectively.
25I-radioact vity in other tissues and blood amounted to only a trace. After intraportal
injection of microspheres containing 3H(G)-adriamycin, tritium radioactivity was mainly
distributed in the liver. However, the percentage of dose in the liver after administration
of mic spher s containing 3H(G)-adriamycin was smaller than that after injection of i25I-
microspheres. The difference might result from release of adriamycin from microspheres
in t  blood and liver and rigid binding of i25I-radioactivity. The adriamycin released might
distribute to other tissues. This view was supported by the finding that tritium levels (%)
in issu s other than the liver were higher than i25I-levels (%), as shown in Fig. 3. At 10 min,
1 hr, and 1 day after injection of microspheres containing 3H(G)-adriamycin, the tritium
levels of the free fraction of adriamycin were 1.21, O.90, and O.37% per gram of liver, and the
free fr ctions were 1110, 1113, and 1/32, respectively.
    Figure 4 shows the total amount of radioactivity in the liver (% of dose) at 10 min, 1hr,
and 1 day after intraportal injection of free of microsphere-entrapped 3H(G)-adriamyciR,
or i25I-microspheres, as well as the total amount of radioactivity in the liver after intravenous
injection of free 3H(G)-adriamyciR or i25I-microspheres. Adriamycin in the liver was almost
eliminated at 1 day after intravenous or intraportal injection of the free drug. In contrast,
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                   Radioactivity (% of dose/g tissue)
Fig. 3. Tissue Distributions oP25I- and 3]E[-Radioactivities at 10 min, 1 hr,
 and 1 day after Intraportal Injection of i25I-Microspheres or Non-labeled
 Microspheres containing 3H(G)-Adriamycin
     {ZZZil ; i25I-microspheres,
     n; microspheres containing aH(G>-adriamycin, F and M; free and microsphere
    fraction (see the text).
    Each column represents the mean value of 4-5 rats. Vertical bars indicate S.E.M.
3H- and i25I-radioactivities even at 1 day after intraportal injection of microspheres were very
high. At 10 min after intravenous injection of i25I-microspheres, 85.3% of the dese was incor-
porated in the whole liver, and even at 1 day, 79.7% of the microspheres remained in the liver.
                                These results indicate that the microspheres prefer-
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Fig. 4. Tissue IDistributions ef i25I-
 and 3H-Radioactivities in the Liver
 after Injection of Microspheres or
 Adriamycin
 O; i25I-microspheres after intravenous in-
   ]ectlon,
 pt ; i25I-microspheres after intraportal injec-
   tion,
 K; microspheres contaiaing 3H(G)-adria-
   mycin after intraportal injection,
 A; free SH(G)-adriamycin aiter intravenous
   lnJectlon,
 A; free 3H(G)-adriamycjn after intraportal
   in]'ection.
 Each point represents the mean value of
 4-7 rats.




entially distribute into the liver, and that a high level
is maintained in the liver. Radioactivity in the liver
after intraportal injection of i25I-micresphers was
slightly higher than that after intravenous injection.
This result might be explained by the difference in the
amount of microspheres first-passed in the liver.
    Figure 5 and Table I compare the antitumor ef-
fects of free and microsphere-entrapped adriamycin,
and microspheres without entrapped drug against AH
7974 liver metastasis. When 106 cells of AH 7974
ascites were inoculated into the portal vein in rats,
the aRimals died between 10 and 16 days later due to
the metastasis (control in Fig. 5), and the median
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F!g. 5. Effect of IntrapoTtally Administered Adri-
 amycin or Microspheres on AH 7974 Liver Me-
 tastasis in Rats
     ..-+-------; controi,
       ; free adrlamycin,
     --; microspheres containing adriamycin,
     -,-･-; microspheres without drug.
No. 5 1437
TABLE I. Effect of Intraportally Administered Adriamycin or
    MicrospheTes on AH 7974 Liver Metastasis in Rats
Survivala)





















a) Mean value±, S.E.M.
b) Calculated for 8 rats that suryived for less than 60 days.
c) Calcuiated for 10 rats.
survival time was 13.0 days. Injection of free adriamycin or microspheres without entrapped
drug did not give any significant difference in survival from the control. In contrast, 2 out
of 10 rats survived over 60 days after administration ot microspheres containing adriamycin;
t  median survival time of the other 8 rats was 19.5 days and TIC % was 150.
Discussien
    The development of a suitable method 'for the preparation of drug-containing albumin
microspheres requires a knowledge of the physicochemical properties of the agents. The'
stability of drug--albumin aqueous solution in cottonseed oil emulsions and the particle size of
albumin microspheres might be infiuenced by the viscosity of the mixed agueous solution
at the first step of the preparation of microspheres. The adriamycin content in the present
microspheres was O.15mglmg, which was higher than the 5-fluorouracii content (O.033mg/mg)
in microspheres reported elsewhere.i,7) The difference of drug contents in microspheres might
be due to a difference of drug leakage from microspheres at the washing stage of microspheres
in the preparation, and this in turn might depend on differences of physicochemical interactions
between albumin and drug, andlor change of the molecular mobility in the microspheres due
to the difference of molecular size (130.08 molecular weight for 5-fiuorouracil and 579.98 for
adriamycin). As shown in Figure 1, the microspheres containing adriamycin exhibited sus-
ained drug release. Since the burst effecti2) as observed in the case o'f in'vitro 5-fiuorouracil
release from microspheres7) was not observed in the case of adriamycin release, the efuciency
Qf adriamycin entrapment in the microspheres appears to be higher than that of 5-fiuorouracil.
The release mech nism of drugs from microspheres is very complex, and further study is needed
in order to un ers and the release characteristics of albumin microspheres containing various
chemotherap utic gents. We plan to study the effect of solidification temperature during
preparation on the in vitro release of adriamycin.
    After intravenous or intraportal injection, albumin microspheres were mainly distributed
in the liver (Figs, 3 and 4). Microspheres after intravenous injection also distributed in the
lung, but this was not the case after intraportal injection. If the drug or microspheres them-
selves caused side effects, especially in the lung, intraportal injection would be better than
intravenous injection. Further if tumor cells and microspheres were released through the
same route, they might disperse to the same sites in the body. Therefore, intraportal injection
might be more useful than intravenous input against metastasis frem gastric cancer to the
liver through the portal vein.
    From the results of Figure 5 aRd Table I, adriamyciR entrapped in the microspheres shows
a greater effect on liver metastasis than free adriamycin or non-entrapped microspheres, or the
control. TIC % for rats treated with microspheres without entrapped drug was 115, suggesting
that the microspheres physically interacted the tumor cells. The number of the tumor cells
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inoculated in rats in this experiments was 106 cells per rat, whereas the amouRt of microspheres
was 2mg weight (2×108 particles).i3} Thus, a metastatic tumor cell might be surrounded
by scores of microspheres. The microspheres which were approaching the tumor cell might
be phagocytized in the cell, or might reiease the entrapped adriarfiycin. Since microspheres
containing adriamycin show sustained release (Fig. 1), an effective level of adriamycin may
be maintained around the tumor cell.
    In conclusion, the present results that albumin microspheres show sustained release of
adriamycin, preferentiai distribution in the liver after intraportal injection, and preventive
effects on AH 7974 !iver metastasis dernonstrate the superiority of intraportal injection of
microspheres in adjuvant chemotherapy of liver metastasis. It should be possibie to improve
the ethcacy of antitumor agents entrapped in microspheres by the improvement of the in
vitro drug release characteristics.
   Acknewledgement The authors thank Dr. Hiroshi Sato, Sasaki Institute, for valuable suggestions
and for providing AHI 7974 cells.
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BIOMEDICAL APPLICATIONS OF MAGNETIC FLUIDS. I.GUIDANCE OF FERRO-COLLOID-ENTRAPPEDMICROSPHERE FOR SITE SPECIFIC DRUG DELIVERY
YASUNORI MORIMOTO, KENJI SUGIBAYASHI, MUTUO OI<UMURA AND
FIf7c'u!(y q/'Phai'maceutic'al Scien('es, ufosai Uni},ef'si4?, 1--1 Keyakidoi, Sakado,




        Magnetic guidance of magnetic albumin microsphere for site specific drug delivery
was investigated in yivo . After intravenous iRjection in mice, magnetic microspheres localized
in the site (lung) at which two permanent magnets were placed. Injection into the renal artery
in rats aiso indicated that the microspheres were concentrated at the kidney by a magnecic
field. When magnet was Rot applied, however, the microspheres were concentrated mainiy in
the liver. Such preferential localization by magnetic meaRs suggested chat magnetic albumin
microspheres could become effective drug carriers with sice specificity for the deiivery of
chemotherapeutic agents in cRncer therapy.
        Keywerds magnetic aibumin microsphere; magnetic fluid; drug carrier; site
specificity; drug delivery; magneEic guidance
  Localization of chemotherapeutic agents to
specific sites would reduce the systemic dose of a
griven drugr while still achieving efiibctive iQcal
concentration of the drug. One chemical
approach to targeting chemotherapeutic agents is
inclusion of the agents within carriers. Recent
examples include efltrappment of daunomycin
into DNAt) and other antitumor agents into
liposomes.2':S) NXIe recently reported that 5-
fluorouracil encrapped in albumin microspheres
was present in hi.trh levels in the liver of mice after
intravenous injection,4+5) and suggested suscained
release and prolonged action of entrapped drug
occurred in Ehrlich ascites6) and solid carcinoma.7}
However, intravenous injection ef such liposomes
and microspheyes results in their uptake predomi-
naRtly by the reticuloendothelial system,4-5･S)
especially the Kupffer cells in the liver.9> More
recently, Widder et al.iO> suggested that since
magnetic microspheres injected into the ventral
caudal artery could be localized to some extent to
a predetermined tail segment by an externaHy
applied magnetic fieid, magneticaliy guided
'i' Average diameter of the colloidal particles is l OO ---- 200 AJ
albumin microspheres entrapped drugs would be
useful as a rug delivery system with site
sp ciflicity.
  The experiinental developments in this
approach have be  prevented by two difEiculties,
i.e. the cont ol ofa magnetic field at a target topi-
cal si e and the preparation of an active drug with
a magnetically responsive character. If site specific
drug deiiv ry of antitumor agents couid be
achieved w th magnetic means, this deiivery
system may eliminate adverse side effects ghat are
often the sequelae ofgenerated systemic drug dis-
tribution. This paper describes the utility of mag-
netic albumin m crosphere as a dyug carrier with
target specificity by meastiring microsphere leveis
in the lung and kidney after intravenous and
intra-renal-arterial administration, respectively.
  Magnetic albumin microspheres were prepared
with bovine serum albumiR, i25I-human serum
albumin (50 ptCi/ml,JapaR Radioisotope Associa-
t on) and magnecic fluid'" (Type N>U-35, Taiho
Industries Co., Ltd･) by a modification of the
method of Widder et al.ii) The final
Magnelic' GLiidbnce Q/'A lbLtmin il4icf'osphef'e
microspheres contaiR abouE 50% magnetite
(Fe304). Two types ofmicrospheres, namely small
microsphere (1 pam in average diameter) and
large microsphere (3 ythm), were used in the
experlments.
  In the first experimencs, the mouse lung was
selected as a model for in vivo testing of
microspheres fbr two reasons. (D The lung tumor
occupies high ratios in many maligRancies. (ii)
The microspheres aftey intravenous injection pass
through the iung until sequestration in the liver.
One mg of small or large microsphere was
injected into the tail vein in ICR mice, weighing
about 30 g, as O.2 ml of a suspension. Two mag-
net (Super Disc Magnet, No. 30730, Edmund
Scientific Co) with a magnetic introduction of
about 3000 Gauss were placed on the breast and
back of mice throughout the experiment so as to
concentrate the microsphere into the lung. Mice
were killed 10 min after administration, and i25I-
iabeled microspheres in various tissues wefe deter-
mined by an Auto-gamma scintillation spec-
rometer (Type 5110, Packard).
  The rat kidney was selected fbr a model in the
s cond experiments. It is difficult to collect the
microspheres in other tissues except the luftg or
heart frJer intravenous injection, theR the route of
the administration was chaRged to intra-artery.
Administrat on of the microspheres through the
renal artery was carried out by cannuiating a
polyethylen  tubing and forming a new vessel
bypas ing the origiRal artery, because the
polyethylene tubing is easy for injection. One mg
of small microsphere was injected into the left re-
nal arte y n male Wistar rats weighing about
22eg. Twe magRets were directly placed
th oughout the experiments at the both sides of
left kidney which was exposed by a midline
abdominal incision. Distribution of microsphere
10 and 60 min after administration was examined
by the method described previously. The distribu-
tion of i25I-albumin microspheres to various
organs is represented as % of dose per gram tissue
or that in whole tissue.
  The experimental results in mice were shown
in Fig. 1. After intravenous injectiofi of small
265
microspheres iR mice without magfiet (cofltrol),
about 3.9% of the administered dose (15.8%ig
tissue at the concentration) was fbund in the lung.
When the pafticle siz  of the microspheres was
enlarged from i to 3 @m in diameter, uptake of
microsphere in the lung increased from 39% of
dose (15.8%/g t ssue) to 10.7% (51.7%ig). This
resuits may indicate, considering thac blood
capillary is narrow, chat the large microspheres
iead to the o c usion of the capillary. VUhen two
magne s were app ed to the lung, however, the
microsphere l v l in the lung increased about
four-fold for smaH microsphere and twice for
I rg  microsphere compared with each control.
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FIG. 1 . 7HZssue Distt'ibution oj'Radioactivity at 1 0 min
 cv7er intravenous 1njection of Magnetic M}cro-
 sphere (Z and3pam in dinmeteO
   A; 1 pam in average diameter, B; 3 gem in
 averagediameter. [=] ;control(homagrzeO,
  ･:･:･:･:･:･: ; trearmeiit with two magnets throughout
 the experiments. EZzch cohtmn represents the mean
 yalue of 3-5 experiments. Vertical bars indicate
S.EM
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i:IG. 2. 7-Zssue Dist/"ibution qf'Radioactiviity at 10 and
 60 min qfZe7' A(iministf'ation into the Lefl Renal.
 Ai'teiy qf'Magnetic A<fici'osphq/'e (1 pa m in diameleO
  [=) ;controlQiomagneO, :･:･:･:･:･:･ ;treat-
 ment with two magnets thf"oughout the expei'iments.
 Etzc'h eolumn i'epi'esents the mean yalble qf3 {?txperi-
 ments. Y?i'tical bai's indicate S.E.M
level (104.0%ig tissue) was measured, but the
amount ofthe microspheres in the lung was only
216% of the dose. V<Zhen the strengrh of mag-
netic field is increased, this value (21.6%) mi.oht
be improved considering that Widder e4 a/.iO)
used high magneEic field strength (8000 oersteds)
to retain 37-65% microspheres inco the Eail after
infusion through the ventral caudal arcery.
  After intravefious injection, the microspheres
did not concentrate in the kidney and localized
rr}ainly in the liver as fnentioned above."'"' Though
the data are not illustrated, intravenous injectioR
in rats applied two magnets at the kidney did not
increase in the microsphere level in the magnet
site.ti"+ Microsphere level in the kidney after
intra-renal-arterial administratieR (Fig. 2, cofitrol)
was higher than that in the experiments of
intravenous injection with and withouc magnets.
Administration into the rat kidney with magnets,
on the other hand, concentrated about 56% of the
dose (48%Lg tissue) in the kidney at 10 min as
shown in Fig. 2 (treatment with two magnets),
and the value was about 2.5-fold higher than that
in the control. The microsphere.level in the
kidney at 60 min was not different frofn that at
10 min, which suggested that the microspheres in
the kidney were retained by the magnets.
  A carrier system for the site specificity of
chemotherapic agents by magnetic means is a
unique idea and magnetic albumin microspheres
may provide a new means of treatment in cancer
chemotherapy. Presently, we plafl to investigate
the applicability of such drug carriers co several
experimental tumor systems.
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 Lag Time involved in the Experiments on Drug Release from Ointmentsi)
        KENx FuJiwARA, MicHiHiRo UEDA aRd TAMoTsu KoizuMi2)
           1::acaltl, of Phar7nacezttioal Sciences, (Llniz'erslty of Toyama2)
                        (Received May 9-,, i975)
   Explicit expression was derivecl for the lag time due to drutg accumulation in the
diffusion layer ef the sinl< solution, xvhich is encountered at experiments on drug release from
ointments.
    Higuchi's equation (Eq. 1) that expresses the amount (e) of drug released froiu the oint-･
iinent, in which the initial drvtg concentration is Ce, lnto a perfect sink clciring time t, indicates
that the plots of e against square root of t give a straight line through the origin.
           9==2CoN/-wwtt Ilq.1                   :L
    In pyactice, the straight line does not always pass the origin but shows some time lag.3>
One reasoR for this is explained by the well known lag time of Barrer,`i) which is a measyire
of the period required for the accumulation of the drug in the membrane, if the membrane is
used, (and in the diffusion Iayer of the sink solution at the Reighbor of the oiRtment). Ii" the
drug concentration in the ointment is constant, Barrer's lag tirne is given by
                h2           TB= -6rfi- eq.2were h is the thickness of the membrane and D is diffusior} constant. In the case of drug
release experiments, however, drug concentration in the ointment is not constant but decreases
every mmute.
    Aim of this note is to express theore'ticaliy the lag time observed under sttch experimentak"
sltuatloRs.
Theoretical
    ]Let Di be the diffusion consta rt in the di£fusion layer, the thickRess of which is h, and D..
that in the ointment. Also, let C, be the concentration in the diffusion Iayer and C. that
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              ny,2t'"-21,;t9.,gi,;t:t) (2n+i)erf,{
l'; or large t, Eq. 11 be ome
           9 = 2CinN/ D;'t nv (-il}i'i-)PCinh IEIq･ 12
Therefore the lag time clue to drgg accumulation in
t'he diffusion layer is given by Eq. 13.
           Lagtime==({]t')2-t-42g?//-                                Eq. 13
                   dCedCi                         (x -= O)       == Do   Di             dx dx
           Co == PCi (.-.･ == O)
           C,=O (x=:-h)
          2 = D f:("<liCxi )..mhdt
where P is the partition coeificient oi the drug at the interface (x=O)
    SolutSon to these equations with the indicated boundar
of the method given by Carslaw and Jae.crer.5> The amount of
is expr ssed by Eq. 11.
           g == J.4111ii.ilil, v`-ii?..i.t- ,;l.l,('-,PivV,`"l/lli Z.,(=(27,i.+s)li,,linvl
                               fDi n
Discussien
    Lag time calculated in this note is a measuye
of the period required for buil(ling-up of drug
concentratien in the diffusion layer. Another lag
time is present when the diffusion constant o£ the
drug in he m mbrane s smaller than that in the
bulk. Appendix of the p evious report6> deals
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        Detoxication Capacity of a Multiple (wlo/w) Emulsien for the Treatment
               of Drug Overdose: Drug ExtractieR into the Emulsion
                     in the Gastre--intestinal Tract of Rabbits
             YASUNoRI MORIMOTO, KENJI SUGIBAYASI{I, YUI<IYA YAMAGUCHI,
                               and Yosmo KATo
                   1:;aczdlJy qf P7tav'?']zaoe7･tlical Scie7･zoes, fosai UniweysityU
                             (Received Ju]y 23, 1979)
         The drug extraction ability of v"rater-in-oil-in-water einuls.ion was eva}uated in vitro
      and in vivo. 17･?. vilro drug extraction into the emulsion was deterinined usins, a dialysis
      systern and was significant compared to the control. Blood concentration of salicyclic
      acid, selected as a model drug, co-administered with the inukiple emulsion to rabbits
      was signtacantiy }ower than that in the control. The in vitro and in vivo experimental
      i-esujts su.cr.tvest that t}'}e emulsion may be useful for the einergency ts'eatment of drus,
      overdose.
         Keywords wfofw ernu}sioR; detoxlcationJ drug overdose; (lrug' extraction;
      salicylic acid; emergency treatment for clru.cr over(loseJ rabbit
    Poisoning due to drug overdose is a continuing problem. The present modes of einer-
geRcy treatment are airned at removal of the drug from the body by various methods, e. g.
peritoneal dialysis, ingestion of adsorbaRts such as activated charcoal, and administration
of emetics. However, these methods have limitations.
   Water-in-oil-iR-water (wlo/w) emulsion represents a potential new drug-carrier system
with the ability to facilitate gastro-intestinal absorption.2} Asher et al.3) also showed tl}e
1) Location: 2-i, Ke3,ahidai, Sak･aao, Saitama, 350-e2 faPan.
2> R.H. Engel, S.J, Riggi, and M.J. Falirenbach, Nature (London), 219, 856 (1968).
3) VYr.J. Asher, IK.C. Bovee, J.W. Frankenfeld, IR.W. HamiXon, L.W. Henderson, P.G. Holtzapple, and
   N.N. Li, Kidne.v fnt., 7, s-409 (1975).
No. I2 3189
(Visl<ing Co,) (ava,ilable area--3.80 cm2).
diffusion cell used in the pr,esent exp. eriments is
shovLrn in Fjg,. 1. ki cell A, 50 mi of emulsion
was niixed wi lrt 5(} ml of {}.(}59,6 CZI]ABIO.OlN HCI
solution at a dr g' concent tion of IOO ing/50 ]nl
or 1{)()e i g, 50 n ], ancl leO ml oi O.()1N HCI "ras
placed in ce}l IB. [irhe whole system was main-
tained at 37±, l" using a xvater bath. At ap-
propriate intervals, alic]uots oi 1 m} of HCI solii--
tion were ",ithdra.wi3 from cell IB aRcl cletermined
speetrophotometricall>r.
   .bz Yivo Experiment V/nanesthetized male
white rabbits weit-yhi g .D" to 3 l<g were used. Food
was withheld for 24 hr before･ each experiment.
Salicylic acid was suspended in e.OlN I{[Cl with
O.05% CTAB at a concentration of 20mg,lml.
This suspension xvas prepared iinmediate}y prior
to administration and given through a catheter
O.OlN HC! as a control (9 v iutmes) was orally
3.8% sodium citrate solution and assayed,
utility of such a multiple emulsion for the removal of uremia toxiBs. Recently, Frankenfeld
et al.4) reported the in vitro removal of salicylates and barbiturates by w!olw emulsiox, and
they suggested that the emulsien was capable of rapid uptake of the drug in vitro.
    We therefore selected salicylic acid as a model drug aBd measured the blood levels
following oral administration of water-in-oil-in--water emulsion in rabbits to investigate the
feasibility of Frankenfeld's suggested emergency treatment for drug overdose in vivo.
                                     Experimental
   IVEaterials Salicylic acid xxras of J.P. gra(Ie, an(l was used after passage through a No. 150 test sieve.
Liquid parafEln x･xras used as an oii phase for the emulsion. A nonionic surfactant, Arlacel C (Tol<yo Kasei
Kogyo Co.), and a cationic surfactant, cetyltrimethylammonium bromide (CTAB) (VXral<o Pure Chemical
l'ndustries, Lt,dl.), were selected as the stabi]izing agene and dispersing agent for tke continuous aqueous
phase, respectively.
   Preparation of tke M[ttltiple Emulsion Twenty 9f.f (vlv) Arlacel C in liquid paraffLn as an oil phase and
O.1N NaOH as a central aqueous pbase (1: 1) were mixed and stirred with a magnetic stirrer for 5 min to
prepaye the wlo emulsion (lst emtdsification). Nii)e volumes of e.OlN HCI containin.cr O.059/, C'II)AB (con-
tmuous aGueous phase> were aclded to the resulting emulsion and mechanical agiration completed the forma-
tion of the w!olw dispersion (2ncl emulsification) (Chart O.
               i, ..i..l.i...9:.l.-lj.-I)I/g9lj..... li ii. o: 2e % Ariacei c/iiqu'id pafa'f'-il'il"l/
                     l/..um . ...... .. mm..nv.-ww.I
                     ii lst en3tilsification
                     t
               i ' -"""' "nv--'-ww'ua-""      ,..}.}l..f.(..9...9..f.p...ylt/lfo/mmn.rm../t l..-w..e.:9...:.Oi..2S..9.'TAE./o･giN.-.H....c....{'lll
                     i "l                     l- ..reww-.-.....,".......-... ... ........ . ...... .l                     I 2nd emulsification
               /.nvB}.} .ltiple (wi/o/sr2) emulsion I/
              Claart 1. Schematic Diagram of the Preparation of the w/o/w Emulsion
   n V tro Experimeitt ln viti'o drug extrac--
tion into the ei:nulsion was deteninined by (ily- sampiing sitenam c dia}vsis through acellulose menibrane ee
                                           cell A                   cell B
emulsion 50ml






           celllilosef  stirrer membrane stirrer1
 Fig. 1. Apparatus used for the Extraction of
  Salicylic Acid into xv･lo/w IEmulsion
                              ] ading into the stomach (16mg!k.cr). The emulskon or
                           administered at the same time. At appropriate                                               times,venous blood sa.n)ples (e.9 ml each> were collected from an ear vein with a one ml syringe containing O.1 ml of
                         for drug content.
4>a> J.W. Frankenfeld, C. Fuller, and C.T. Rhodes
G.C. Fuller, J.W'. Frankenfeld, and C.T. Rbodes,
, D7'ug Dett. Commasn., 2, 405 <1976> ; b) C.-X]X'. Chiang,
f. Pharm Sci , 67, 63 (1978).
   Analytical Methods Salic}Tlic a.eid samplEs obtained during ivt vt'tJ'o e,itvaction expcriments wcre
determined colorimetTicallv at 53e nm usinga Hitachi 100-20 spectTophotometer aEter reuction with FeCl,
solution. Blood sampres lvere assayed using a I{itachi 650-10S spectrofiuorDphotometer by the method of
Ro"'land et al.S)
Results and
    The emulsiQns prepared as described
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Fig. 2. Photoniicrograpli of Oil Dreps I)ispevsed
 i" t]ie Continuous Aqucous Phase












are milk-"rl]ite, and contain splierical oil
continuou  aqu ous phase (Fig. 2). Tlie
diam'eter of the oil drops was mbstly in
the range of 12 to 30 pm, and the average
diameter was 19 um.
    T]ie emulsion was stable du[lng slow
stirring, but if stirring was stopped, it
sepaTated into two layers and tlie oil
phase was gradually se.crregated into the
upper layer. Dilute emulsions were more
stal)le than cencentrated emulsions. Be-
cause salicylic acid is a weak acid, O.1 N
NaOH was selected as a trapping agent
for the central aqueous phase (w,), and
this agent did not infiuence t]ie stability
of the emulsion.
    In the case o£ in vitro drug extrae-tion experiments into emulsions, ]?ig. 3
shows the amounts Qf salicylic acid that
passed from cell A to cell B through a
cellnlose membrane with trapping by the
emulsion, The amount$ o[ drug in cell B
apparently decreased wl]en emulsion was
present in cell A. In Fig. 3a Csolution
type), the initial amount in cell A was
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Fisr. 3, The Eff,ect of Extraction of Salicylic Acid inte the Emu]sion
 en Jts PeTmeabilitv through a Cellalose Memt)ra"c
                e; vvith eiautsiell. O; control,
.:]) ]･I. Rowland and S. Rie.rrclman,J. Pltarm, Sei.. 56, 717<lg67),
No, 12 319.I
was disselved in the solutio . Hoxvever, in Fig. 3b Csuspension type), the initial arnount was
1000mg; about -O-90ft, of th'e drug was dissolved in solution and 7S% was solid particles.
These figures confiirn the abilitv o'f the emulsion to remove salieylic acid.6)
    The time eourse ol blood 'concentration of salicy]ic acid following oral adniinistration
iiito rabbits is shosum in Fig. 4, Tl]e blood concentratjon in rabbits treated with the emul-
sions was lower than tliat in t]ie control.
Tl]e results sutscrgest that the eniulsion n]ay be
use{ul tar die emersrencs' treatment o{ drug
overdose. Moreover, the emulsion ean be
readily prepared using simple equipTnent,
such as n ordinary kiclien blender, and thus
mig]it be useful as ELn eniergency home trcat-
ment for clrug overdo,sc, Basecl on the data
obtained in rabbits treated with andi witl]out
emu sions, we coinparecl tlie peak concen-
trations, the times of the peak croncentra-
tions, and the areas "nder the blootl-cwnc".fi-
tration-time curves (AUC), as shownin Table
I. The peak conce.ntration foJlowing co-
administration o[ sa]icvlic acid and emulsion
was 40% less tlian tbat in the control. Tl)e
peak concentratien is the most iinportmit
factorin the onset ef poisoning. The de'crease















 Salicvlic Acid after Oial .eLdministratian
       evviUiemulsieTt,O:co:]tro],
    Encb paint reprcst:]ts the mea:t va]!1e of fOur
   experiments. Vftrtical barg indicatc ± S. E, M.
 12345 6hr           Tini[t
Tirne C urse of Blood Coneentration ot'
1. ':]lw Pealc Conec:r]tratien, the Ti-ie of tl]e Pea}t Conccntratio-
and the Area undttr tlie ISIood Concentrution-time Profiles
     nfter C)ral Adaiinistratitm of Salicylic Acid
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  l48.3
1()9.5 + 1,l .8
R -- /' n. el
,sion is consistent with a process of detoxication. The time at whicl] the peak concentration svas
established xvas al]out 1 hr, and this indicates that the absorption step was completed earlier
than in the control., which is consistent witli a decrease of absorbable drug content in the
stomach due to extractlQll o[ the drug into the emulsion. The area under the curve ftom
6') The dlssolvtio] of soiid diugpaiticles, drug extraction into the emuls{on, ana dials$is through a Viskiug
  ]nembrane all obey lirGt-odcr kinetics. An ana]iniis of the data as shown in Fi.g. 3 could be simulated
  llsim.cr t-he compartrnellt model with an a"alog co;nputer, ctc, Thus, tlie time course af ex±raction ol the
  clrvtsr in±o the etnulsions shoulcl be predictable. These results will be reported else"'1]ere.
3192 Vol. 27 (1979)
0 to 6 hours was measured by the trapezoidal methed. The resuKing AUCe-6 was 46% less
than that in the control experiments. The values of the peak coRceRtration aRd AUCe-6
were significantly different from those of the controi @<O.Ol).
                                Il                   i/ solid drug particles l
                                        S dissolution
                                 I±                                 I, drug in solution l/
                           absorption i l extract!on
                           l Il l                           i, drug in bleod i' idrug in emulsion 11
                     Chart 2. The Processes of Absorption and Extraction
                      into the Emulsion after Ingestion oi Salicylic Acid
    Upon administratioR of excess drug, however, a large portion remains as a solid in the
stomach, so the dissolution rate of the drug might affect the drug extraction capability of
the emulsioR (Chart 2). If the extractioR potential into the emulsions is saturated, the
unextracted portion of the drug will be absorbed into the blood. This might be overcome
by continuous infusion of the emulsioR.
    The amount of drug absorbed into the blood and extracted into the emulsions in the
stomach were infiuenced by the gastric contents, Iik our experiments, rabbits were fasted
during the entire day before oral administratioR. However, there was some gastric content
cltte to coprophagy by the rabbits, and this might affect the stability of the emulsioA in the
stomach with resulting changes iB the bloed level of the drug.
    Chiang et al.4b) reported in vitro studies showing that the extraction of a drug into the
erculsion decreased in the presence of bile salt. We did not observe any effect of bile salts
on drug extraction by the emulsion in viwo in this study, but furtheer work is planned.
    These experimental results suggest that w/olw emuisions x[tay be u$eful for the emergency
treatment of drug overdose. IHowever, there are still maRy difficulties facing clinical trials
of the emulsion. Studies are presently under way in our laboratory to improve the stability
of the wlolw emulsion and tQ mal e it capable of rapid uptake of many weakly acidic drugs.
In addition, we plan to investigate the usefulness of the emulsion following ingestion of basic
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ニ　■　　　　’と　 ゾ）　「山 4　》　11」31改：そ「レ　及　ひ　rl　l　Lξ腹 1　ト「　 ；L二　：　 仁　；　重　 と　 rL　　と　 しに　ど　Lノノ　 ジ　’　 l　r　r⊆
い親慶に蔵少しでいr二．二のli／罰の身過につ江て，放
1｛1盾性が［1㌔1か」』、恥二lrll化管内を「回書へ向けて移心する
ノ）　i　 に ，　　　 1詳甘　1．’蜀］　二套　．1勿の　 1移動　 ≧　9i旦7　　，」　」1＝　1’1111　　L　こ　 ゲ）　 」ト‘「1勿を よF［1しゾ　1 I　I　1
ト　「卜　 ‘i［1．，O　：　1　1二　11＝嗣～　1’トPj　多　 し，　 ，　し ！ ＿旨　　　1こ　 よ　　モ5　　ぜ，　 ノ ｝　　と　拝f＿ デ111」　さ　 P｝　ヒ　　る　
甲
　F「［1生ラノ　ト1，こllC－DIP－Pをllrlr11収1勺｛史1∫・1F　rこ！1113；t，　1貨
「ノ・優ユ5分で肝臓、腎臓，lMし臓，胃に高い孜帰r刮生が認
められ，小腸及び心1「繍よ低、纏った．lI班rl111では小腸7」；
高く、肝臓は15分よりも低下した，3時闘後ては．小
ll級び1肖1にIII1叙■IF臓に中城「艘、、ゼめら、11、121［鋼後rξ
は小腸に高い放q・］イ園生を認めるの《で，魁の臓皆ll及び
祖織中には垣跡癌1度しか荏在し加かりた．
　L℃一D【P－Pの吊壬II｝貨1済1憂15ニナ『〔汁北．　1マ及こメ’1唄易にII∴1
く，次いで腎臓，肝臓、ll市，心臓にも放射活性が認め
られた．3哨・間後では．冑から小腸への馬丁につ珪して
小1陽に高い放射活性が存在L，胃にも謳められたが，
肝臓1脳礼臓，腎トi轍よそれ程高くはなかった，工2時尚後
ては，胃に比較r甲高い放・射盾性が仔住L．小腸内容物
中にもわずかでにあるか盾性が認められた，
　MC－disopyramid巳　のII浄1派1勾｛」ど㌻1丞…ジ）で一　1・ラ　ジ十
ワラ．τ・は「4C－D王P－Pの追申「ノ1投ケの結果と矧似してト
1り▽没日後15分．〔やよ，肝臓，qlli，小1湯に高い放射’1身性
が，怨められ，次いで副腎，心臓虹には1悩にもかすかに
認めら泊た，1111F間で俄，肝臓，小腸及ひ：胃に高く，
他の臓器ではかなr，低下し，31トむ幽間では．小腸に顕宮
な放11・D刮’」三が認めらわた，121111・IIII↓隆ては『小腸と胃に
II月らかな！l劉・17山1生帆、醒yp引1た．
考 察
　DIP・Pをな丑娠ラ’トに1国浄脈内投与した時，放射盾性
ば［Ill中から急」鵬∴11匠失したが、ユ2！1y闘巨に明らかな梅
IYAKUHIN　KENKYU　Vol．12　No．2〔1981）
たが認めろ，｝1だ，「｝ill｝FのD正P．Pの犀L｛生→ソトへの静
脈内投1’時のln［中濃L度においても，1鰍1間日にわずか
で宇よある，，；籾Z人＝ウく、i怒y）ら計しノこことより，di写opyraロlide
に汰血中濃度を増加させる要囚，すなわち二の場rτ胆
汁」非Illトが多いことDから，陽肝循環の存在が推剛され
る，この12117間II1竃にとらわれずrこ差引II御法で111［li二物
哩一i1巨霊曲線の式をゴビめると　放射活t生の消失過程ぽ
2材1に分離することができた，すなわ㌧第1剛てに血
F†ゴ1笥成期が0．60時闘であ軌第2田でほユ6，6時闘であ
った．ヒ1［性ラントの易r㌃け：1旧邸三縄力「3旧であった‘へ
妊軌く時でぱ捗少異なるものと思われる．
　一・方様「’1紳1周11量をZ渦ヒ、投厨融811ト1間雲でに
1樹rへ33．5％，親中へ47．O％ヒ糞lllへll［：1111さIIたlrl㌧♂1・
はるかに多かった．この傾向は，1陥1の創生ラ・トへ
のDIP－Pの静脈1勺投学「卜1∫の111Fとよく類「塗している　ま
た蓄hl｛1生も比較ビド1低いものと思われる．
　妊娠ラ㌧1・にD【PPを「ト削厩内投’ア後15分ず6放ll・lr』［」k
l罰台維を順過し，胎仔に移行する二とが認められたが、
以侵胎臼二内濃度は、母体血中濃度の急激な低下に比例
するようにす職やかに1肖失していく二とが明らかと／よ
っ仁
　史に穿娩後9日目の母ズットの静脈1ANこDIP－Pを投
’∫L畑芋の15多懸の租［中濃度は、母体血・膿度，助
絢5倍高か’け二が，その消失に非常にすみやかで工5分
直に比lli吏すると，511｝間値で削合よそ／0分の1となっ
ていた
　一寸．一トラジ＋グラムでな初氏一日トへの投1ア1釦紛，
1時間、31麟lll　12ill糊と1・・ずれの場i｝も胎仔への移
1∫｝よ少ないことがll月らかとなった．肝臓，腎臓，　I17、
小腸に比し陵的IIト’篤い放射活性が認められノ＝二，比校のた：め
に行一，た雌性テ・・トへの1「℃一D【P－Pの経口及び」移脈内
1魁、1超樹ポ℃一disopyramideのll診脈1柵愛1溢のオ
一目 gラジ・1’プラムから、本1尾1験に目1いたdisopyrarnide
亭」二　・月窒に二1］予臓，∵琴1「佐．胃，｝」、岨易1こ』ゐ肖…しゃすし・ことカ・
II月らかと厘ノた．まに、投与12時間後でも胃及び小腸
に高い放射ア凶具を示していることから（Fig．6．7，8）、
この細物ゆ胃からの停泌｝乏・捌凹嗣」助1・rlfr三ヒヒか刊「訓
コ1た幽
結 論
　DIP－Pを妊娠ラ・’トにi浄脈盲亀ワして，一ζの1匡L転職
度，3睦尿中排阻，胎仔r笥】’．庭にぽ乳汁1’獅1を一一「，
以下の綜最を得た．
634 森本ら　DIP－Pの体内動態（第冠報）
　1．静脈内投与後，放射活性はすみやかに組織に移
行又は排泄されて，血中濃度はユ2時間目の極大を無視
すると，2相性のすみやかな減少を示した．
　2．糞尿中排泄量は，48時間で80．5％であり，糞中
排泄：量の方がはるかに多かった．
　3．胎仔への放射活性の移行はすみやかであるが，
母体血中濃度の急激な低下につれて，すみやかに消失
していった．
　4．乳汁移行はすみやかであり，かつ母体血中濃度
より高いが，血中濃度の急激な低下に比例的にすみや
かに減少した．
　5．妊娠ラットのオートラジナグラムから，この薬
物は胎盤を通過し，胎仔へ移行することが認められた
が，その程度は微量であり，かつすみやかに消失した．
　　　　　　　　　文　　献
1）森本雍憲，杉林堅次，中村祐子，中西邦夫，灘井
　種：一，代田博文，中島元信，医薬品研究，12，620
　（1981）．
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